10-Q000160980412/312020FYFALSE33.3333.3333.3300016098042020-01-012020-03-31xbrli:shares00016098042020-05-06iso4217:USD00016098042019-01-012019-03-31iso4217:USDxbrli:shares00016098042020-03-3100016098042019-12-3100016098042018-12-3100016098042019-03-310001609804us-gaap:CommonStockMember2019-12-310001609804us-gaap:TreasuryStockMember2019-12-310001609804us-gaap:AdditionalPaidInCapitalMember2019-12-310001609804us-gaap:RetainedEarningsMember2019-12-310001609804us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001609804us-gaap:RetainedEarningsMember2020-01-012020-03-310001609804us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001609804us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001609804us-gaap:CommonStockMember2020-01-012020-03-310001609804us-gaap:CommonStockMember2020-03-310001609804us-gaap:TreasuryStockMember2020-03-310001609804us-gaap:AdditionalPaidInCapitalMember2020-03-310001609804us-gaap:RetainedEarningsMember2020-03-310001609804us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001609804us-gaap:CommonStockMember2018-12-310001609804us-gaap:TreasuryStockMember2018-12-310001609804us-gaap:AdditionalPaidInCapitalMember2018-12-310001609804us-gaap:RetainedEarningsMember2018-12-310001609804us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310001609804us-gaap:RetainedEarningsMember2019-01-012019-03-310001609804us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310001609804us-gaap:AdditionalPaidInCapitalMember2019-01-012019-03-310001609804us-gaap:CommonStockMember2019-03-310001609804us-gaap:TreasuryStockMember2019-03-310001609804us-gaap:AdditionalPaidInCapitalMember2019-03-310001609804us-gaap:RetainedEarningsMember2019-03-310001609804us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-31oec:facilityoec:sales_companyoec:holding_companyoec:service_companyoec:operating_entityxbrli:pure0001609804oec:CologneGermanyMember2020-03-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2020-03-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2019-12-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2014-07-250001609804oec:TermLoanUSDMemberoec:TermLoanMember2014-07-25iso4217:EUR0001609804oec:TermLoanEURMemberoec:TermLoanMember2014-07-250001609804oec:TermLoanEURMembersrt:MinimumMemberoec:EuroInterbankOfferedRateEURIBORMemberoec:TermLoanMember2014-07-252014-07-250001609804oec:TermLoanUSDMembersrt:MinimumMemberoec:TermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMember2014-07-252014-07-250001609804srt:MaximumMemberoec:TermLoanEURMemberoec:EuroInterbankOfferedRateEURIBORMemberoec:TermLoanMember2014-07-252014-07-250001609804srt:MaximumMemberoec:TermLoanUSDMemberoec:TermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMember2014-07-252014-07-250001609804oec:TermLoanEURMemberoec:EuroInterbankOfferedRateEURIBORMemberoec:TermLoanMember2014-07-252014-07-250001609804oec:TermLoanUSDMemberoec:TermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMember2014-07-252014-07-250001609804oec:TermLoanMemberoec:TermLoanFacilityMember2014-07-252014-07-250001609804oec:TermLoanEURMemberoec:TermLoanMember2015-01-012017-12-310001609804oec:TermLoanUSDMemberoec:TermLoanMember2015-01-012017-12-310001609804oec:TermLoanUSDMemberoec:TermLoanMemberus-gaap:LondonInterbankOfferedRateLIBORMember2020-01-012020-03-310001609804oec:TermLoanEURMemberoec:EuroInterbankOfferedRateEURIBORMemberoec:TermLoanMember2020-01-012020-03-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2020-01-012020-03-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2018-01-012018-12-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2017-01-012017-12-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2016-01-012016-12-310001609804oec:TermLoanMemberoec:TermLoanFacilityMember2019-01-012019-03-310001609804us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:CashFlowHedgingMember2018-05-110001609804oec:TermLoanMemberoec:TermLoanFacilityMember2018-05-112018-05-110001609804us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2015-01-010001609804us-gaap:CurrencySwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMember2020-03-310001609804us-gaap:RevolvingCreditFacilityMember2014-07-250001609804srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberoec:EURIBORAndLIBORMember2014-07-252014-07-250001609804srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberoec:EURIBORAndLIBORMember2014-07-252014-07-250001609804us-gaap:RevolvingCreditFacilityMember2017-05-042017-05-040001609804us-gaap:RevolvingCreditFacilityMember2017-05-052017-05-050001609804us-gaap:RevolvingCreditFacilityMember2017-05-050001609804us-gaap:RevolvingCreditFacilityMember2019-04-022019-04-020001609804us-gaap:RevolvingCreditFacilityMember2019-04-010001609804us-gaap:RevolvingCreditFacilityMember2019-04-020001609804us-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMember2019-04-022019-04-020001609804srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2019-04-020001609804srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2019-04-020001609804us-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMember2019-04-012019-04-010001609804us-gaap:RevolvingCreditFacilityMemberus-gaap:EurodollarMember2020-01-012020-03-310001609804srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2020-03-310001609804srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2020-03-310001609804us-gaap:RevolvingCreditFacilityMember2020-01-012020-03-310001609804us-gaap:RevolvingCreditFacilityMember2019-01-012019-03-310001609804us-gaap:RevolvingCreditFacilityMember2020-03-310001609804us-gaap:RevolvingCreditFacilityMember2019-12-310001609804us-gaap:RevolvingCreditFacilityMemberoec:DeutscheBankAGMember2020-03-310001609804us-gaap:RevolvingCreditFacilityMemberoec:DeutscheBankAGMember2019-12-310001609804us-gaap:RevolvingCreditFacilityMemberoec:UnicreditMember2020-03-310001609804oec:UnicreditMember2019-12-310001609804us-gaap:FairValueInputsLevel2Member2020-03-310001609804us-gaap:FairValueInputsLevel2Member2019-12-310001609804us-gaap:FairValueInputsLevel2Memberoec:CreditFacilityTermLoanMember2020-03-310001609804us-gaap:FairValueInputsLevel2Memberoec:CreditFacilityTermLoanMember2019-12-310001609804oec:LocalBankLoanMemberus-gaap:FairValueInputsLevel2Member2020-03-310001609804oec:LocalBankLoanMemberus-gaap:FairValueInputsLevel2Member2019-12-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001609804us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-03-310001609804oec:TwoThousandSixteenPlanMember2020-01-012020-03-310001609804oec:TwoThousandSixteenPlanMember2019-01-012019-03-310001609804oec:TwoThousandSeventeenPlanMember2020-01-012020-03-310001609804oec:TwoThousandSeventeenPlanMember2019-01-012019-03-310001609804oec:A2018PlanPaymentTransactionMember2020-01-012020-03-310001609804oec:A2018PlanPaymentTransactionMember2019-01-012019-03-310001609804oec:A2019PlanCEOIncentiveMember2020-01-012020-03-310001609804oec:A2019PlanCEOIncentiveMember2019-01-012019-03-310001609804oec:A2019PlanMember2020-01-012020-03-310001609804oec:A2019PlanMember2019-01-012019-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandSeventeenPlanMember2019-12-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandSeventeenPlanMember2020-01-012020-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandSeventeenPlanMember2020-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandEighteenPlanMember2019-12-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandEighteenPlanMember2020-01-012020-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandEighteenPlanMember2020-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandNineteenPlanMember2019-12-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandNineteenPlanMember2020-01-012020-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandNineteenPlanMember2020-03-310001609804us-gaap:PerformanceSharesMember2019-12-310001609804us-gaap:PerformanceSharesMember2020-01-012020-03-310001609804us-gaap:PerformanceSharesMember2020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandEighteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeNewHireSignOnMember2019-12-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandEighteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeNewHireSignOnMember2020-01-012020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandEighteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeNewHireSignOnMember2020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandNineteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeNewHireSignOnMember2019-12-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandNineteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeNewHireSignOnMember2020-01-012020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandNineteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeNewHireSignOnMember2020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandNineteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeExistingEmployeesMember2019-12-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandNineteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeExistingEmployeesMember2020-01-012020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberoec:TwoThousandNineteenPlanMemberoec:ShareBasedPaymentArrangementEmployeeExistingEmployeesMember2020-03-310001609804us-gaap:RestrictedStockUnitsRSUMember2019-12-310001609804us-gaap:RestrictedStockUnitsRSUMember2020-03-310001609804us-gaap:ShareBasedPaymentArrangementNonemployeeMemberus-gaap:RestrictedStockMember2020-03-310001609804us-gaap:RestrictedStockUnitsRSUMember2019-03-310001609804us-gaap:PerformanceSharesMember2019-03-310001609804us-gaap:PerformanceSharesMember2018-03-310001609804us-gaap:RestrictedStockUnitsRSUMember2018-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandSeventeenPlanMember2020-03-012020-03-310001609804us-gaap:PerformanceSharesMemberoec:TwoThousandSixteenPlanMember2019-04-012019-04-300001609804us-gaap:CostOfSalesMember2020-01-012020-03-310001609804us-gaap:CostOfSalesMember2019-01-012019-03-310001609804us-gaap:SellingAndMarketingExpenseMember2020-01-012020-03-310001609804us-gaap:SellingAndMarketingExpenseMember2019-01-012019-03-310001609804us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-03-310001609804us-gaap:GeneralAndAdministrativeExpenseMember2019-01-012019-03-310001609804us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-03-310001609804us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-03-310001609804us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockUnitsRSUMember2020-01-012020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2020-01-012020-03-310001609804us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2020-01-012020-03-310001609804us-gaap:EmployeeSeveranceMember2019-12-310001609804us-gaap:FacilityClosingMember2019-12-310001609804oec:GroundRemediationCostsRelatedToRestructuringMember2019-12-310001609804us-gaap:OtherRestructuringMember2019-12-310001609804us-gaap:EmployeeSeveranceMember2020-01-012020-03-310001609804us-gaap:FacilityClosingMember2020-01-012020-03-310001609804oec:GroundRemediationCostsRelatedToRestructuringMember2020-01-012020-03-310001609804us-gaap:OtherRestructuringMember2020-01-012020-03-310001609804us-gaap:EmployeeSeveranceMember2020-03-310001609804us-gaap:FacilityClosingMember2020-03-310001609804oec:GroundRemediationCostsRelatedToRestructuringMember2020-03-310001609804us-gaap:OtherRestructuringMember2020-03-310001609804us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310001609804us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310001609804us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-03-310001609804us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-03-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-03-310001609804us-gaap:AccumulatedTranslationAdjustmentMember2020-03-310001609804us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310001609804us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310001609804us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2018-12-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310001609804us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-03-310001609804us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-01-012019-03-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-03-310001609804us-gaap:AccumulatedTranslationAdjustmentMember2019-03-310001609804us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-03-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-03-310001609804us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-310001609804us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-03-310001609804us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2019-01-012019-03-31oec:defendant0001609804us-gaap:UnfavorableRegulatoryActionMemberus-gaap:SettledLitigationMember2020-01-012020-03-310001609804country:US2020-01-012020-03-310001609804us-gaap:UnfavorableRegulatoryActionMembercountry:USsrt:MinimumMemberus-gaap:SettledLitigationMember2020-03-310001609804srt:MaximumMemberus-gaap:UnfavorableRegulatoryActionMembercountry:USus-gaap:SettledLitigationMember2020-03-310001609804us-gaap:UnfavorableRegulatoryActionMembercountry:USus-gaap:SettledLitigationMember2018-01-012020-03-310001609804us-gaap:UnfavorableRegulatoryActionMemberus-gaap:SettledLitigationMember2018-01-012018-12-310001609804oec:TermLoanUSDMemberoec:TermLoanMember2020-03-310001609804oec:TermLoanEURMemberoec:TermLoanMember2020-03-31oec:guarantee0001609804oec:EulerHermesS.A.Member2020-03-310001609804oec:EulerHermesS.A.Member2019-12-310001609804oec:DeutscheBankAGMember2020-03-310001609804oec:DeutscheBankAGMember2019-12-31oec:segment0001609804us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberoec:RubberMember2020-01-012020-03-310001609804us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberoec:RubberMember2019-01-012019-03-310001609804us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberoec:SpecialtiesMember2020-01-012020-03-310001609804us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMemberoec:SpecialtiesMember2019-01-012019-03-310001609804oec:RubberMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310001609804oec:SpecialtiesMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310001609804us-gaap:CorporateNonSegmentMember2020-01-012020-03-310001609804oec:RubberMemberus-gaap:OperatingSegmentsMember2019-01-012019-03-310001609804oec:SpecialtiesMemberus-gaap:OperatingSegmentsMember2019-01-012019-03-310001609804us-gaap:CorporateNonSegmentMember2019-01-012019-03-31oec:related_party0001609804us-gaap:EquityMethodInvesteeMember2020-01-012020-03-310001609804us-gaap:PrincipalOwnerMember2020-01-012020-03-310001609804srt:AffiliatedEntityMember2020-03-310001609804srt:AffiliatedEntityMember2019-12-310001609804srt:AffiliatedEntityMember2020-01-012020-03-310001609804srt:AffiliatedEntityMember2019-01-012019-03-31

UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _______________ to _______________

ORION ENGINEERED CARBONS S.A.
(Exact name of registrant as specified in its charter)
Grand Duchy of Luxembourg 001-36563 00-0000000
(State or other jurisdiction of incorporation or organization)
(Commission file number)
(I.R.S. Employer Identification No.)
4501 Magnolia Cove Drive Suite 106
Houston,
Texas
77345
(Address of Principal Executive Offices)
(Zip Code)
(281) 318-2959
Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, no par value OEC New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.       Yes x    No  o 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes  x   No  o 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, "smaller reporting company" and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer
Non-accelerated filer  
Smaller reporting company
Emerging growth company




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes ☐   No  x

The registrant had 60,487,117 shares of common stock outstanding as of May 6, 2020.



TABLE OF CONTENTS

PART I - Financial Information
1
Item 1. Financial Statements and Supplementary Data (unaudited)
1
Consolidated Statements of Operations of Orion Engineered Carbons S.A. (Unaudited)
1
Consolidated Statements of Comprehensive Income of Orion Engineered Carbons S.A. (Unaudited)
2
Consolidated Balance Sheets of Orion Engineered Carbons S.A. (Unaudited)
3
Consolidated Statements of Cash Flows of Orion Engineered Carbons S.A. (Unaudited)
4
Consolidated Statements of Changes in Stockholders’ Equity of Orion Engineered Carbons S.A. (Unaudited)
5
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
25
Item 3. Quantitative and Qualitative Disclosures About Market Risk
36
Item 4. Controls and Procedures
36
PART II - Other Information
36
Item 1. Legal Proceedings
37
Item 1A. Risk Factors
37
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
38
Item 3. Defaults Upon Senior Securities
38
Item 4. Mine Safety Disclosures
38
Item 5. Other
38
Item 6. Exhibits
39
SIGNATURES
40






PART I - Financial Information
Item 1. Financial Statements and Supplementary Data (unaudited)

Consolidated Statements of Operations of Orion Engineered Carbons S.A. (Unaudited)

Three Months Ended March 31,
2020 2019
(In thousands, except per share amounts)
Net sales $ 336,007    $ 384,714   
Cost of sales 245,815    286,745   
Gross profit 90,193    97,969   
Selling, general and administrative expenses 44,519    55,577   
Research and development costs 4,956    5,129   
Other expenses, net 3,175    2,475   
Restructuring expenses —    89   
Income from operations 37,543    34,699   
Interest and other financial expense, net 9,610    6,443   
Reclassification of actuarial losses from AOCI 2,398    —   
Income from operations before income taxes and equity in earnings of affiliated companies 25,534    28,256   
Income tax expense 7,635    9,439   
Equity in earnings of affiliated companies, net of tax 133    137   
Net income $ 18,032    $ 18,954   
Weighted-average shares outstanding (in thousands of shares):
Basic 60,276    59,518   
Diluted 61,391    61,113   
Earnings per share:
Basic $ 0.30    $ 0.32   
Diluted $ 0.29    $ 0.31   
Dividends per share $ 0.20    $ 0.20   

The accompanying notes are an integral part of these consolidated financial statements.


1



Consolidated Statements of Comprehensive Income of Orion Engineered Carbons S.A. (Unaudited)

Three Months Ended March 31,
2020 2019
(In thousands)
Net income $ 18,032    $ 18,954   
Other comprehensive loss, net of tax
Foreign currency translation adjustments (24,071)   1,463   
Unrealized net gains/(losses) on hedges of a net investment in a foreign operation 36    —   
Unrealized net gains/(losses) on cash flow hedges (656)   (2,225)  
Gains/(losses) on defined benefit plans 1,847    53   
Other comprehensive loss (22,844)   (709)  
Comprehensive income $ (4,811)   $ 18,245   

The accompanying notes are an integral part of these consolidated financial statements.

2



Consolidated Balance Sheets of Orion Engineered Carbons S.A. (Unaudited)
March 31, 2020 December 31, 2019
(In thousands, except share amounts)
Current assets
Cash and cash equivalents $ 107,540    $ 63,726   
Accounts receivable, net of expected credit losses
of $7,454    and $6,632    234,532    212,565   
Other current financial assets 19,245    11,347   
Inventories 168,481    164,799   
Income tax receivables 7,819    17,924   
Prepaid expenses and other current assets 32,072    37,358   
Total current assets 569,688    507,718   
Property, plant and equipment - net 535,237    534,054   
Operating lease right-of-use assets 29,718    27,532   
Goodwill 75,427    77,341   
Intangible assets - net 48,124    50,596   
Investment in equity method affiliates 5,235    5,232   
Deferred income tax assets 56,291    48,720   
Other financial assets 692    2,501   
Other assets 3,434    3,701   
Total non-current assets 754,157    749,676   
Total assets $ 1,323,845    $ 1,257,394   

Current liabilities
Accounts payable $ 145,342    $ 156,298   
Current portion of long term debt and other financial liabilities 144,854    36,410   
Current portion of employee benefit plan obligation 886    908   
Accrued liabilities 31,939    44,931   
Income taxes payable   14,927    14,154   
Other current liabilities 35,712    32,509   
Total current liabilities 373,659    285,211   
Long-term debt, net 619,879    630,261   
Employee benefit plan obligation 69,472    71,901   
Deferred income tax liabilities 54,056    43,308   
Other liabilities 39,963    40,701   
Commitments and contingencies Note M
Total non-current liabilities 783,371    786,171   
Stockholders' equity
Common stock
Authorized: 65,035,579 and 65,035,579 shares with no par value
Issued – 60,992,259 and 60,729,289 shares with no par value
Outstanding – 60,487,117 and 60,224,147 shares
85,323    85,032   
Less 505,142 and 505,142 shares of common treasury stock, at cost
(8,515)   (8,515)  
Additional paid-in capital 62,930    65,562   
Retained earnings 84,283    78,296   
Accumulated other comprehensive loss (57,206)   (34,362)  
Total stockholders' equity 166,815    186,013   
Total liabilities and stockholders' equity $ 1,323,845    $ 1,257,394   

The accompanying notes are an integral part of these consolidated financial statements.
3



Consolidated Statements of Cash Flows of Orion Engineered Carbons S.A. (Unaudited)
Three Months Ended March 31,
2020 2019
(In thousands)
Cash flows from operating activities:
Net income $ 18,032    $ 18,954   
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant and equipment and amortization of intangible assets 23,845    24,095   
Amortization of debt issuance costs 501    535   
Share-based incentive compensation (1,139)   3,553   
Deferred tax (benefit)/provision (1,865)   (2,913)  
Foreign currency transactions 1,219    935   
Reclassification of actuarial losses from AOCI 2,398    —   
Other operating non-cash items 360    1,028   
Changes in operating assets and liabilities, net of effects of businesses acquired:
(Increase)/decrease in trade receivables (31,097)   (12,623)  
(Increase)/decrease in inventories (11,681)   7,946   
Increase/(decrease) in trade payables 4,391    3,868   
Increase/(decrease) in provisions (11,365)   (20,821)  
Increase/(decrease) in tax liabilities 12,016    1,748   
Increase/(decrease) in other assets and liabilities that cannot be allocated to investing or financing activities (711)   (134)  
Net cash provided by operating activities $ 4,905    $ 26,171   
Cash flows from investing activities:
Cash paid for the acquisition of intangible assets and property, plant and equipment $ (50,851)   $ (22,487)  
Net cash used in investing activities $ (50,851)   $ (22,487)  
Cash flows from financing activities:
Repayments of long-term debt $ (2,006)   $ (2,018)  
Cash inflows related to current financial liabilities 109,813    37,082   
Cash outflows related to current financial liabilities —    (22,823)  
Dividends paid to shareholders (12,045)   (11,904)  
Taxes paid for shares issued under net settlement feature (1,202)   —   
Net cash used in financing activities $ 94,560    $ 337   
Increase (decrease) in cash, cash equivalents and restricted cash $ 48,614    $ 4,021   
Cash, cash equivalents and restricted cash at the beginning of the period 68,231    61,604   
Effect of exchange rate changes on cash (6,630)   (200)  
Cash, cash equivalents and restricted cash at the end of the period $ 110,215    $ 65,425   
Less restricted cash at the end of the period 2,675    4,504   
Cash and cash equivalents at the end of the period $ 107,540    $ 60,921   
Cash paid for interest, net $ (4,345)   $ (6,024)  
Cash (paid)/refund for income taxes $ 2,259    $ (8,764)  
Supplemental disclosure of non-cash activity:
Liabilities for leasing - current $ 2,982    $ 5,144   
Liabilities for leasing - non-current $ 1,242    $ 25,587   

The accompanying notes are an integral part of these consolidated financial statements.
4




Consolidated Statements of Changes in Stockholders’ Equity of Orion Engineered Carbons S.A. (Unaudited)

Common stock
(In thousands, except per share amounts) Number of common shares Amount Treasury shares Additional paid-in capital Retained earnings Accumulated other comprehensive loss Total equity
Balance at January 1, 2020 60,224,147    $ 85,032    $ (8,515)   $ 65,562    $ 78,296    $ (34,362)   $ 186,013   
Net income —    —    —    —    18,032    —    18,032   
Other comprehensive loss, net of tax —    —    —    —    —    (22,844)   (22,844)  
Dividends paid - $0.20    per share    —    —    —    —    (12,045)   —    (12,045)  
Share based compensation —    —    —    (2,632)   —    —    (2,632)  
Issuance of stock under equity compensation plans 262,970    291    —    —    —    —    291   
Balance at March 31, 2020 60,487,117    $ 85,323    $ (8,515)   $ 62,930    $ 84,283    $ (57,206)   $ 166,815   

Common stock
(In thousands, except per share amounts) Number of common shares Amount Treasury shares Additional paid-in capital Retained earnings Accumulated other comprehensive loss Total equity
Balance at January 1, 2019 59,518,498    $ 84,254    $ (8,683)   $ 63,544    $ 39,409    $ (19,628)   $ 158,896   
Net income —    —    —    —    18,954    —    18,954   
Other comprehensive loss, net of tax —    —    —    —    —    (709)   (709)  
Dividends paid - $0.20    per share    —    —    —    —    (11,904)   —    (11,904)  
Share based compensation —    —    —    3,553    —    —    3,553   
Balance at March 31, 2019 59,518,498    $ 84,254    $ (8,683)   $ 67,097    $ 46,459    $ (20,337)   $ 168,790   
The accompanying notes are an integral part of these consolidated financial statements.

5



Notes to the Condensed Consolidated Financial Statements of Orion Engineered Carbons S.A. (Unaudited)
Note A. Organization, Description of the Business and Summary of Significant Accounting Policies 
        Orion Engineered Carbons S.A.’s unaudited condensed consolidated financial information include Orion Engineered Carbons S.A. and its subsidiaries (“Orion” or the “Company”). The unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019. The accompanying unaudited condensed consolidated financial statements include all adjustments that are necessary for the fair presentation of our results for the interim periods presented. Results for interim periods are not necessarily indicative of results to be expected for the full year.
The Company is a leading global manufacturer of carbon black products and is incorporated in Luxembourg. Carbon black is a powdered form of carbon that is used to create the desired physical, electrical and optical qualities of various materials. Carbon black products are primarily used as consumables and additives for the production of polymers, printing inks and coatings (“Specialty Carbon Black” or “Specialties”) and in the reinforcement of rubber polymers (“Rubber Carbon Black” or “Rubber”).
The Company manufactures Specialty Carbon Black for a broad range of specialized applications such as polymers, printing systems and coatings applications. The various production processes result in a wide range of different Specialty Carbon Black pigment grades with respect to their primary particle size, structure and surface area/surface chemistry. These parameters affect jetness, tinting strength, undertone, dispersibility, oil absorption, electrical conductivity and other characteristics.
The types of Rubber Carbon Black used in the rubber industry are manufactured according to strict specifications and quality standards. Structure and specific surface area are the key factors in optimizing reinforcement properties in rubber polymers.
        As at March 31, 2020, the Company operates 13 wholly owned production facilities in Europe, North and South America, Asia and South Africa and three sales companies and another nine holding companies and six service companies, as well as two former operating entities in Portugal and France (currently in dissolution). Additionally, the Company operates a joint venture with one production facility in Germany.
The Company's global presence enables it to supply Specialty Carbon Black customers as well as international customers in the tire and rubber industry with the full range of carbon black grades and particle sizes. Sales activities are supported by sales and representative offices all around the globe. Integrated sales activities with key account managers and customer services are carried out in the United States, Brazil, South Korea and Germany and China.
Risks and Uncertainties

We are subject to risks and uncertainties as a result of the current outbreak of a novel strain of coronavirus (COVID-19). The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict. Furthermore, capital markets and economies worldwide have also been negatively impacted by the COVID-19 pandemic, and it is possible that it could cause a local and/or global economic recession. Such economic disruption could have a material adverse effect on our business. Policymakers around the globe have responded with fiscal policy actions to support the chemical industry and economy as a whole. The magnitude and overall effectiveness of these actions remains uncertain.

The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers and suppliers, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, supply chain disruptions, lower demand for our products, commodity price volatility, heightened price sensitivity among customers, higher competitive intensity, inventory revaluations, and the impact of any initiatives or programs that the Company may undertake to address financial and operations challenges faced by its customers. As of the date of issuance of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

Summary of Significant Accounting Policies
Revenue and Income Recognition

        The Company recognizes revenue when or as it satisfies a performance obligation by transferring a good or a service to a customer. Revenue is only recognized when control is transferred to the customer. The amount of consideration we receive and revenue we recognize is based upon the terms stated in the sales contract, which may contain variable consideration such as discounts or rebates. We also give our customers a limited right to return product that has been damaged or does not satisfy their specifications, or for other specific reasons. Payment terms on product sales to our customers typically range from 30 to 90 days.  Although certain exceptions exist where standard payment terms are exceeded, these instances are infrequent and do not exceed one year.

6



Revenue is recognized according to the five-step model prescribed in ASC 606. Under the first step, the entity has to identify the contract entered with a customer granting the right to receive goods or service in exchange for consideration. The second step requires the identification of distinct performance obligations within a contract. The transaction price of the arrangement is defined in Step 3 of ASC 606. In addition to the contractual fixed price the entity has to take variable considerations into account. If the entity identified more than one separate performance obligation under step 2, it has to account for this contract as a multiple element arrangement resulting in an allocation of revenues to the obligations identified. If these conditions are satisfied, revenue from the sale of goods is recognized when control have been transferred to the buyer, either at a point in time, or over time.
        
The Company derives a substantial majority of revenues from selling carbon black to industrial customers for further processing. Revenue recognition and measurement is governed by the following principles. The amount of revenue and the transaction price is contractually specified between the parties and measured at the amount expected be received less value-added tax and any trade discounts and volume rebates granted. Discounts and volume rebates are accounted for as estimates of variable consideration and deducted from revenue.
        
With respect to the sale of goods, sales are recognized at the point in time control over the good transfers to the customer. The timing of the transfer of control varies depending on the individual terms of the sales agreement.

The Company's business is organized by its two carbon black product types. For corporate management purposes and all periods presented the Company had “Rubber” and “Specialty” as reportable operating segments. Rubber carbon black is used in the reinforcement of rubber in tires and mechanical rubber goods; Specialties are used as pigments and performance additives in coatings, polymers, printing and special applications.

Adoption of accounting standards
In March 2020, the FASB issued ASU No. 2020-03, Codification Improvements to Financial Instruments (ASU 2020-03). The amendments in this update affect a wide variety of topics in the codification and represent changes to clarify or improve the codification. The amendments make the codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. Issues 1, 2, 4 and 5 within the standard are conforming amendments and are effective upon issuance of ASU 2020-03. Issue 3 is also a conforming amendment and is effective for fiscal years beginning after December 15, 2019. Issues 6 and 7 relate to ASU No. 2016-13 and are effective for fiscal years beginning after December 15, 2019 since Orion previously adopted ASU No. 2016-13 on January 1 2019. The Company adopted ASU 2020-03 as of January 1, 2020. The adoption of this guidance did not have any impact on the Company’s financial statements.
In February 2020, the FASB issued ASU No. 2020-02, Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842)- Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842) (SEC Update) (ASU 2020-02). The new standard as it relates to Topic 326 is effective upon a registrant’s adoption of FASB ASC Topic 326 (adopted by Orion on January 1, 2019). The new standard is as it relates to Topic 842 is not applicable. The adoption of ASU 2020-02 did not have any impact on the Company’s financial statements.
In November 2019, the FASB issued ASU No. 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses (ASU 2019-11). The amendments in this update represents changes to clarify, correct errors in, or improve the codification, and make the codification easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. For entities that have adopted ASU 2016-13, the amendments in ASU 2019-11 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted in any interim period after the issuance of ASU 2019-11 as long as the entity has adopted the amendments in ASU No. 2016-13. The Company adopted ASU 2019-11 as of January 1, 2020. The adoption of this guidance did not have a material impact on the Company’s financial statements.

In May 2019, the FASB issued ASU No. 2019-05, Financial Instruments - Credit Losses (Topic 326) (ASU 2019-05). The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20, Financial Instruments - Credit Losses - Measured at Amortized Cost, with an option to irrevocably elect the fair value option in Subtopic 825-10, Financial Instruments - Overall, applied on an instrument-by-instrument basis for eligible instruments, upon adoption of Topic 326. For entities that have adopted the amendments in ASU No. 2016-13, the amendments in ASU 2019-05 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted in any interim period after the issuance of ASU 2019-05 as long as the entity has adopted the amendments in ASU No. 2016-13. The Company adopted ASU 2019-05 as of January 1, 2020. The adoption of this guidance did not have a material impact on the Company’s financial statements.

In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments (ASU 2019-04). The updates contained in this ASU provide clarification and correction to ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, and ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, and is intended to improve the Codification or correct its unintended application. The amendments in ASU 2019-04 related to ASU No. 2016-01 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted in any interim period following the issuance of ASU 2019-04 as long as the entity has adopted all of the
7



amendments in ASU No. 2016-01. For entities that have adopted the amendments in update 2016-13, the amendments in ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted in any interim period after issuance of ASU 2019-04 as long as the entity has adopted the amendments in ASU No. 2016-13. For entities that have adopted the amendments in ASU No. 2017-12 as of the issuance date of ASU 2019-04, the effective date is as of the beginning of the first annual period beginning after the issuance of ASU 2019-04 (January 1, 2020 for Orion). For those entities, early adoption is permitted, including adoption on any date on or after the issuance of ASU 2019-04. The Company adopted ASU 2019-04 as of January 1, 2020. The adoption of this guidance did not have a material impact on the Company’s financial statements.

In August 2018, the FASB issued ASU No 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans. The guidance changes the disclosure requirements for employers that sponsor defined benefit pension and/or other postretirement benefit plans. It eliminates requirements for certain disclosures that are no longer considered cost beneficial and requires new ones that the FASB considers pertinent. The guidance is effective for financial statements issued for fiscal years ending after December 15, 2020 for public business entities and fiscal years ending after December 15, 2021 for all other entities. Early adoption is permitted. Entities will apply the amendments retrospectively. The Company adopted ASU No 2018-14 as of January 1, 2020 The adoption of this guidance will not have a significant impact on the Company's financial statements.

Principles of consolidation
The consolidated financial statements include all subsidiaries indirectly or directly controlled by Orion. Entities are consolidated from the date Orion obtains control, which generally is the acquisition date, and are deconsolidated when control is lost.
Control is achieved when Orion is exposed, or has the right, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Orion re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of these three elements of control.
Orion consolidated financial statements are prepared in accordance with uniform accounting policies. Income and expenses, intercompany profits and losses, and receivables and liabilities between consolidated subsidiaries are eliminated.
Use of estimates
The preparation of consolidated financial statements in conformity U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from those estimates.
Foreign currency translation
Foreign currency transactions are measured at the exchange rate at the date of initial recognition. Any gains or losses resulting from the valuation of foreign currency monetary assets and liabilities using the currency exchange rates as at the reporting date are recognized in other expenses, net.
Currency exchange differences relating to financing activities are recognized in interest and other financial income and interest and other financial expense.
The assets and liabilities of foreign operations with functional currencies different from the presentation currency U.S. dollars are translated using closing rates as at the reporting date. Income and expense items are translated at average monthly exchange rates for the respective period. The translation of equity is performed using historical exchange rates. The overall foreign currency impact from translating the statement of financial position and income statement of all the foreign entities is recognized in accumulated other comprehensive income (loss) ("AOCI").
8



Note B. Recent Accounting Pronouncements Not Yet Adopted
In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04). The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update are effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the potential impact the adoption of this standard will have on its financial statements.
In January 2020, the FASB issued ASU No. 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815). The amendments in this update clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. The amendments in this update are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. The Company is currently evaluating the potential impact the adoption of this standard will have on its financial statements.
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

9



Note C. Leases
Orion has entered into lease contracts as a lessee and is not acting as a lessor. The vast majority of Orion’s lease contracts are concerning operational items such as rail cars, company cars, offices and office equipment.
The recorded right-of-use assets as of March 31, 2020 amounted to $29.7 million, and the corresponding lease liabilities amounted to $31.3 million, of which $8.6 million were recorded within other current liabilities and $22.7 million as other liabilities. 
The weighted remaining average minimum lease period is 2.7 years.
The undiscounted minimum lease payments are due in and reconcile to the discounted lease liabilities as follows:
March 31, 2020
(In thousands)
Next 12 months $ 8,593   
1 to 2 years 7,291   
2 to 3 years 6,391   
3 to 4 years 5,578   
4 to 5 years 4,301   
More than 5 years 4,644   
Total undiscounted minimum lease payments 36,799   
Discount (5,501)  
Lease liability (current and non-current) $ 31,298   

The weighted average discount rate applied to the lease liabilities is 6.43%.
Finance lease costs were immaterial for the three months ended March 31, 2020. Operating lease costs amounted in total to $3.2 million for the three months ended March 31, 2020 and were recorded as operating expenses under cost of sales, selling, general and administrative expenses and under research and development cost. Cash paid for amounts included in the measurement of lease liabilities from operating leases was $2.2 million for March 31, 2020 and $2.7 million for the three months ended March 31, 2019 and was immaterial for finance leases during the same periods.
In addition to the above, we entered into a forward-starting lease agreement in October 2016, for a district heating facility in Cologne, Germany, where we plan to operate the equipment to generate the required heat energy. The lessor, the public utility of our neighbor city and its agents, is currently constructing the facilities at our location, with the lease scheduled to commence by the end of 2020 after construction is completed. The lease agreement will have a total of approximately $35.0 million in undiscounted future lease payments over the 20 year term of the lease.




Note D. Inventories
Inventories, net of obsolete, unmarketable and slow moving reserves are as follows:
March 31, 2020 December 31, 2019
(In thousands)
Raw materials, consumables and supplies, net $ 76,637    $ 69,168   
Work in process 35    148   
Finished goods, net 91,808    95,483   
Total $ 168,481    $ 164,799   
Orion periodically reviews inventories for both obsolescence and loss in value. In this review, Orion makes assumptions about the future demand for and the future market value of the inventory and, based on these assumptions, estimates the amount of obsolete, unmarketable or slow moving inventory.
The balance of the reserve for obsolete, unmarketable and slow moving inventories amounted to $6.7 million as of December 31, 2019. The additions, net to the reserve during the quarter ended March 31, 2020 amounted to $3.4 million (prior year: $0.1 million), of which $2.9 million were related to adjust inventories to net realizable value (prior year: nil). The balance of the reserve as of March 31, 2020 increased therefore to $10.0 million. The adjustment to net realizable values was recorded on raw materials, consumables and supplies and on finished goods.
11



Note E. Debt and Other Obligations
The company had the following debt arrangements in place as of March 31, 2020 and December 31, 2019:
March 31, 2020 December 31, 2019
(In thousands)
Current
Term loan $ 7,952    $ 8,057   
Deferred debt issuance costs - term loan(1)
(1,366)   (1,409)  
Other short-term debt and obligations 138,267    29,762   
Current portion of long term debt and other financial liabilities 144,854    36,410   
Non-current
Term loan 624,164    634,994   
Deferred debt issuance costs - term loan(1)
(4,285)   (4,733)  
Long-term debt, net 619,879    630,261   
Total $ 764,733    $ 666,671   

(1) According to ASU 2015-03, adopted on January 1, 2016, the Company presents debt issuance costs related to a recognized liability as a direct deduction from the carrying amount of that liability.
(a) Term Loan
On July 25, 2014, Orion entered into a refinancing of its indebtedness. The initial term loan credit facility in USD of $895.0 million was allocated to a term loan facility denominated in USD of $358.0 million and a term loan facility denominated in Euro of €399.0 million with both having an original maturity date of July 25, 2021 (the “Term Loans”). Initial interest was calculated based on three-month EURIBOR (for the Euro denominated loan), or three-month USD-LIBOR (for the USD denominated loan) plus a 3.75% - 4.00% margin depending on leverage ratio. For both EURIBOR and USD-LIBOR a floor of 1.0% applied. At least 1% of the principal amount is required to be repaid per annum; Orion may make additional voluntary repayments. In the years 2015 to 2017 Orion executed several voluntary repayments totaling €56.0 million and $58.0 million.
After several amendments to the credit agreement Orion repriced its EUR- and USD-denominated outstanding term loans during the years 2016 to 2018 and achieved a significant reduction of both interest margins to currently 2.00% for the USD term loan and 2.25% for the Euro term loan. The margin is no longer linked to Orion's net leverage ratio. In addition the EURIBOR and USD-LIBOR floors were reduced to 0.00%. Moreover the durations of both term loans were extended by another three years resulting in a new maturity date of July 25, 2024 (previously July 25, 2021). Other provisions of this credit agreement remained unchanged.
Transaction costs incurred directly in connection with the incurrence of the Euro and U.S. Dollar denominated term loans, thereby reducing their carrying amount, are amortized as finance costs over the term of the loans. Transaction costs incurred in connection with the modifications of the term loan in the years 2016 to 2018 were directly expensed as incurred as the modified terms were not substantially different. In connection with the repricing described above further transaction costs of $0.7 million in 2018 and $3.5 million equivalent in 2017 and $2.1 million equivalent in 2016 were incurred and directly expensed. In 2020, an amount of $0.3 million equivalent related to capitalized transaction costs was amortized and recognized as finance costs in this regard (prior year: $0.3 million equivalent).
On May 11, 2018, Orion entered into a $235.0 million cross currency swap to synthetically convert its US dollar liabilities into EUR to mitigate foreign currency risk. This swap transaction impacts both principal and interest payments associated with debt service and results in a further annual interest payments savings of approximately $4.7 million. The swap became effective on May 15, 2018 and will expire on July 25, 2024, in line with maturity of the term loan.
A portion of the USD-denominated term loan was designated as a hedge of the net investment in a foreign operation to reduce the Company's foreign currency exposure. Since January 1, 2015 the Company had designated $180.0 million of the total USD-denominated term loan held by a Germany based subsidiary as the hedging instrument to hedge the change in net assets of a US subsidiary, which is held by a Germany based subsidiary, to manage foreign currency risk. Due to the new hedging approach utilizing cross currency swap as described above, hedge accounting for the net investment hedge was discontinued on May 15, 2018. An unrealized loss of $2.2 million remains within other comprehensive income until it is recycled through profit and loss upon divestment of the hedged item.
The carrying value as at March 31, 2020 includes the nominal amount of the Term Loans plus accrued unpaid interest less deferred debt issuance costs - term loan of $5.7 million (December 31, 2019: $6.1 million).

12



(b) Revolving credit facility
To generally safeguard the Company’s liquidity, the Company has entered into a revolving credit facility (“RCF”).
As part of the July 25, 2014 refinancing the then-existing revolving facility was replaced by a €115.0 million multicurrency revolving credit facility with an original maturity date July 25, 2019. Interest is calculated based on EURIBOR (for EUR drawings), and USD-LIBOR (for USD drawings) plus 2.5% - 3.0% margin (depending on leverage ratio). The RCF was not drawn on the respective reporting dates while certain local ancillary facilities reduced the available commitment. Transaction costs in the amount of $3.3 million originally incurred in connection with the RCF are also recorded as deferred expenses and are amortized as finance costs on a straight-line basis over the term of the facility (until July 25, 2019).
An amendment to the Credit Agreement entered into on May 5, 2017 (i) reduced the commitment fee paid on the unused commitments from 40% of the Applicable Rate (as defined in the Credit Agreement) to 35% of the Applicable Rate, (ii) extended the maturity date for the revolving credit facility to April 25, 2021 and (iii) increased the aggregate amount of revolving credit commitments to €175.0 million. All other terms of the Credit Agreement remained unchanged.
Additional Transaction costs in conjunction with the RCF in the amount of $2.3 million incurred in connection with the 2017 amendment to the Credit Agreement are also recorded as deferred expenses and are amortized as finance costs on a straight-line basis over the term of the facility (until April 25, 2021).
On April 2, 2019, the Company entered into the eighth amendment (the “Eighth Amendment”) to the Credit Agreement, among the Company and certain of its subsidiaries, as Borrowers or Guarantors, the Lenders from time to time party thereto and Goldman Sachs Bank US, as administrative agent for the Lenders. The Amendment relates to the revolving credit facility (“RCF”) provided by the Credit Agreement. The Eighth Amendment became effective on April 10, 2019.
The Eighth Amendment:
(i) extended the maturity date for the RCF by three years to April 25, 2024,
(ii) increased the aggregate amount of revolving credit commitments in Euro by €75.0 million to EUR €250.0 million, and
(iii) reduced revolving credit interest expense by way of a new pricing grid that entitles an initial margin of 0.019 when the Company's leverage ratio is between 2.25x and 1.75x (formerly 2.5% when leverage ratio was < 2.30x); currently margin is 2.15% as the Company’s leverage ratio is between 2.75x and 2.25x.
All other terms of the Credit Agreement remain substantially unchanged, including the commitment fee, which remains at 35% of applicable margin.
During the first quarter of 2020, transaction costs of $0.2 million were amortized compared to $0.2 million in the first quarter of 2019. Unamortized transaction costs that were incurred in conjunction with the RCF in July 2014, the Amendment on May 30, 2017 and the Amendment on April 2, 2019, amount to $3.2 million as of March 31, 2020. Unamortized transaction costs as at December 31, 2019 amount to $3.4 million and were incurred in conjunction with the RCF in July 2014 and the Amendment on May 30, 2017.
(c) Local bank loans and other short term borrowings
Orion has established additional local ancillary credit facilities for OEC GmbH and OEC LLC by using overall RCF commitments. As of March 31, 2020, the OEC GmbH facilities had $67.2 million (as of December 31, 2019: $26.4 million) outstanding and the OEC LLC facilities had $27.2 million (prior year: $2.2 million) outstanding. The general terms of those ancillary credit facilities are linked to those terms in RCF which is in particular applicable to the interest rates applied.
Note F. Financial Instruments and Fair Value Measurement
The Company measures financial instruments, such as derivatives, at fair value at each balance sheet date. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.
All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the following fair value hierarchy based on the lowest level input that is significant to the fair value measurement as a whole:
Level 1 — Unadjusted quoted market prices in active markets for identical assets or liabilities that the entity can access at the measurement date.
Level 2 — Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices such as quoted prices for similar items in active markets, quoted prices for identical or similar items
13



in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves), and market-corroborated inputs.
Level 3 — Unobservable inputs for the asset or liability.
For financial assets and liabilities that are recognized in the financial statements on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization at the end of each reporting period.
The following table shows the fair value measurement at March 31, 2020 and December 31, 2019. All measurements are based on observable inputs such as interest rates and are classified as Level 2 within the fair value hierarchy:
Fair Value Hierarchy March 31, 2020 December 31, 2019
(In thousands)
Receivables from hedges/ derivatives    $ 16,370    $ 8,436   
Prepaid expenses and other current assets  Level 2 16,364    8,434   
Other financial assets (non-current)   Level 2    
Liabilities from derivatives    $ 8,723    $ 9,425   
Other current liabilities Level 2 49    109   
Other liabilities (non-current)   Level 2 8,675    9,316   
Term loan    Level 2 $ 632,116    $ 643,051   
Local bank loans Level 2 $ 138,267    $ 29,762   

Note G. Employee Benefit Plans
Provisions for pensions are established to cover benefit plans for retirement, disability and surviving dependents’ pensions. The benefit obligations vary depending on the legal, tax and economic circumstances in the various countries in which the Company operates. Generally, the level of benefit depends on the length of service and the remuneration.
Net periodic defined benefit pension benefit costs include the following:
Three Months Ended March 31,
2020 2019
(In thousands)
Service cost $ 303    $ 311   
Interest cost 295    432   
Amortization of actuarial loss 2,398    —   
Net periodic pension cost $ 2,996    $ 743   
Service costs were recorded within income from operations under selling, general and administrative expenses, interest cost in Interest and other financial expense, net.
The actuarial losses associated with the pension obligations recorded in prior years in accumulated other comprehensive income exceeding 10% of the defined benefit obligation are recorded ratably over the current year through profit and loss separately from income from operations and amounted to $2.4 million in the three months ended March 31, 2020.
There are also defined contribution pension plans in Germany and the United States for which our Group companies make regular contributions to off-balance sheet pension funds managed by third party insurance companies.
In South Korea, the Company’s pension plan provides, at the option of employees for either projected benefit or defined contribution benefits. Plan assets relating to this plan reduce the pension provision disclosed.
14



Note H. Stock-Based Compensation
On an annual basis since 2015, the Company has implemented a long-term incentive plan ("LTIP") which grants awards to employees and officers selected by the Compensation Committee of the Board of Directors (the “Compensation Committee”). PSU awards are earned based on achievement against one or more performance metrics established by the Compensation Committee in respect of a specified performance period. Earned PSUs range from zero to a specified maximum percentage of a participant’s target award based on the performance of applicable performance metrics, and are subject to vesting terms based on continued employment.
The first performance period ran from January 1, 2015 through December 31, 2017, with PSUs earned based on achievement of EBITDA metrics established by the Compensation Committee and total shareholder return relative to a peer group. Once earned and vested, PSUs were settled in one common share per vested PSU (or, at the Company’s election, cash equal to the fair market value thereof). There is no exercise price. The first vesting period ran through March 31, 2018 (the “2015 Plan”). All PSUs are granted under, and are subject to the terms and conditions of, the Company’s 2014 Omnibus Incentive Compensation Plan, and do not increase the number of shares previously reserved for issuance under that plan. On August 2, 2016 the Compensation Committee established a consecutive LTIP (the “2016 Plan”) having consistent terms as compared to the 2015 Plan. On March 31, 2019 the vesting period ended for the “2016 Plan” and earned and vested PSUs settled in one common share of the Company per vested PSU - issued to participants on April 30, 2019, except for certain PSUs settled in cash at fair market value to cover wage taxes or as substitute for share transfer restrictions. On July 31, 2017 the Compensation Committee established another consecutive LTIP (the "2017 Plan") having consistent terms as compared to the 2015 and 2016 Plan. On July 12, 2018 the Compensation Committee established a consecutive LTIP (the "2018 Plan") and on July 16, 2019 the Compensation Committee established a consecutive LTIP (the “2019 Plan”). The achievement metrics have changed for the 2019 Plan from EBITDA performance to a 'return on capital employed' and a 'total shareholder return' target. All PSUs are granted under, and are subject to the terms and conditions of, the Company’s 2014 Omnibus Incentive Compensation Plan (the “Omnibus Plan”).
In its “2019 Plan” the company issued beside PSUs ("2019 Plan PSU") also a tranche of restricted share units (“RSUs”) for its selected employees and officers ("2019 Plan RSU"). RSUs vest by one-third on each of the first, second and third anniversary of the grant date. The RSUs are subject to certain further restrictions after vesting. Settlement of selected employees and officer RSUs is within 75 days following the third anniversary of the grant date.
Specific Members of our Executive Committee received RSUs upon signing. These sign-on RSUs vest by one-third on each of the first, second and third anniversary of the grant date.
In April 2018 the Compensation Committee established a stock compensation plan for the Board of Directors under the existing Omnibus Incentive Compensation Plan.
The following table provides detail as to expenses recorded within operating income with respect to stock based compensation:
Three Months Ended March 31,
2020 2019
(In thousands)
2016 Plan
$ —    $ 1,083   
2017 Plan
—    1,195   
2018 Plan
(1,242)   1,275   
Sign on RSU incentive
134    —   
2019 Plan
(30)   —   
Total expenses
$ (1,139)   $ 3,553   
Due to lowered expectations for EBITDA and ROCE in the full year 2020 and upcoming year 2021 performance condition of 2018 Plan and 2019 Plan are no longer expected to be met. Expenses recorded in prior years for 2018 Plan and 2019 Plan were partly reversed for the three months ended March, 31, 2020.
15



In the following table summarizes the activity of our PSUs within the three months ended March 31, 2020:
Period granted
Performance period
PSUs outstanding at January 1,
PSUs granted Performance based adjustment PSUs settled PSUs forfeited PSUs
outstanding at
March 31,
PSUs expected to vest Weighted average grant date fair value
2017 2017 - 2020 418,252    —    (40,087)   (378,165)   —    —    —    $ 24.89   
2018 2018 - 2021 355,766    —    —    —    (2,949)   352,817    299,418    $ 39.24   
2019 2019 - 2022 229,727    —    —    —    (1,895)   227,832    215,933    $ 11.48   
Total 2020 1,003,745    —    (40,087)   (378,165)   (4,844)   580,649    515,351   
In the following table summarizes the activity of our RSUs within the three months ended March 31, 2020:
Period granted Vesting period RSUs outstanding January 1, RSUs granted Performance based adjustment RSUs settled RSUs forfeited RSUs
outstanding at
March 31,
RSUs expected to vest Weighted average grant date fair value
Sign-on RSUs:
2018 2018 - 2021 23,878    —    —    —    —    23,878    23,878    $ 25.81   
2019 2019 - 2022 45,257    —    —    —    —    45,257    45,257    $ 15.89   
2019 Plan:
2019 2019 - 2022 128,447    —    —    —    (1,895)   126,552    126,552    $ 14.74   
Total 2020 197,582    —    —    —    (1,895)   195,687    195,687   
Certain members of our Board of Directors receive compensation in form of restricted shares (“RSs”) in accordance with the 2014 Non-employee Director Plan. Under this plan 24,080 RSs are currently outstanding. The RSs vested on April 30, 2020, the first anniversary of the grant date.
At March 31, 2020, we had unrecognized compensation cost of $5.6 million, based on the target amounts, related to unvested PSUs, RSUs and RSs, which is expected to be recognized over a weighted average period of 1.3 years.
The closing price of the Company's shares and therefore the intrinsic value of one PSU or RSU outstanding was $7.46 as of March 31, 2020, $18.99 as of March 31, 2019 and $27.10 as of March 31, 2018. Total intrinsic value of PSUs and RSUs amounted to $5.8 million as of March 31, 2020, $31.0 million as of March 31, 2019.
The following table lists the inputs to the valuation model used for calculating the grant date fair values under the 2019, 2018 and 2017 Plans:
2017 Plan 2018 Plan 2019 Plan PSU
Expected term (in years) 3 3 3
Dividend yield (%) 1.88% 1.94% 4.65%
Expected volatility OEC (%) 33.77% 30.22% 33.30%
Expected volatility peer group (%) 17.30% 20.09% 17.62%
Correlation 0.4574 0.3659 0.5205
Risk-free interest rate (%) 1.45% 1.46% 1.83%
Model used Monte Carlo Monte Carlo Monte Carlo
Weighted average fair value of PSUs granted $24.89 $39.24 $11.48
In March 2020, 378,165 PSUs (including a performance adjustment reduction of 40,087 PSUs) were settled for the 2017 Plan. In April 2019, 977,106 PSUs (including performance adjustment of 299,499 PSUs) were settled for the 2016 Plan. The expected term of share awards represents the weighted average period the share awards are expected to remain outstanding. The remaining contractual terms of share units outstanding is March 2021 for the 2018 Plan and December 2021 for the 2019 Plan.
The Company used a combination of historical and implied volatility of its traded shares, or blended volatility, in deriving the expected volatility assumption. The risk-free interest rate assumption is based upon observed interest rates appropriate for the term of stock options. The dividend yield assumption is based on the Company's history.
16



Stock-based compensation expense is comprised of the following line items:
Three Months Ended March 31,
2020 2019
(In thousands)
Cost of sales
$ 29    $ 12   
Selling expenses
(172)   737   
General and administrative expenses
(910)   2,598   
Research and development costs
(87)   206   
Stock-based compensation expense
$ (1,139)   $ 3,553   
The assumption for estimating expected forfeitures is based on previous experience and based on 3% leavers rate per year. Actual forfeitures are recorded as they occur. For the three months ended March, 31, 2020 expenses recorded in prior years for 2018 and 2019 Plan were partly reversed as the performance condition for the EBITDA and ROCE metrics are no longer expected to be met.
17



Note I. Restructuring Expenses
Details of restructuring activities and the related reserves for March 31, 2020 were as follows:
Personnel
expenses
Demolition and
Removal costs
Ground
remediation
costs
Other Total
(In thousands)
Provision at January 1, 2020 $ 3,400    $ 561    $ 488    $ 317    $ 4,765   
Charges —    —    —    —    —   
Cost charged against liabilities (assets) —    —    —    —    —   
Cash paid (514)   (402)   (252)   (263)   (1,432)  
Foreign currency translation adjustment (81)   (11)   (14)   (6)   (113)  
Provision at March 31, 2020 $ 2,805    $ 147    $ 221    $ 48    $ 3,221   
Orion's reserves for restructuring are reflected in accrued liabilities on the Consolidated Balance Sheets.
The expenses relate to the Company’s effort to restructure its Rubber segment with a cessation of production at the Company’s French subsidiary and production site by the end of 2016 followed by restructuring of the South Korean footprint in the second quarter of 2018 resulting in cessation of production at the Bupyeong plant and the sale of the land to a third party. In the period ending March 31, 2020 no restructuring expenses, net were recognized compared to restructuring expense, net of $0.1 million in the prior year period ending March 31, 2019.

18



Note J. Accumulated Other Comprehensive Income (Loss)
Comprehensive income (loss) combines net income (loss) and other comprehensive income items, which are reported as components of stockholders’ equity in the accompanying Consolidated Balance Sheets.
Changes in each component of AOCI, net of tax, are as follows for the three months ended March 31, 2020 and 2019.
Currency Translation Adjustments Hedging Activities Adjustments Pension and Other Postretirement Benefit Liability Adjustment Total
(In thousands)
Balance at January 1, 2020 $ (12,281)   $ (10,891)   $ (11,189)   $ (34,362)  
Other comprehensive income (loss) before reclassifications (22,735)   (1,241)   —    (23,976)  
Income tax effects before reclassifications (1,336)   426    —    (910)  
Amounts reclassified from AOCI —    —    2,398    2,398   
Income tax effects on reclassifications —    —    (776)   (776)  
Currency translation AOCI —    195    225    420   
Balance at March 31, 2020 $ (36,353)   $ (11,511)   $ (9,342)   $ (57,206)  

Currency Translation Adjustments Hedging Activities Adjustments Pension and Other Postretirement Benefit Liability Adjustment Total
(In thousands)
Balance at January 1, 2019 $ (10,650)   $ (6,147)   $ (2,831)   $ (19,628)  
Other comprehensive income (loss) before reclassifications 1,532    (3,767)   —    (2,235)  
Income tax effects before reclassifications (69)   1,462    —    1,393   
Amounts reclassified from AOCI —    —    —    —   
Income tax effects on reclassifications —    —    —    —   
Currency translation AOCI —    80    53    133   
Balance at March 31, 2019 $ (9,187)   $ (8,372)   $ (2,778)   $ (20,337)  

The amounts reclassified out of AOCI and into the Consolidated Statement of Operations for the three months ended March 31, 2020 and 2019 are as follows:
Affected Line Item in the Consolidated
Statements of Operations
Three Months Ended March 31,
2020 2019
(In thousands)
Amortization of actuarial losses Reclassification of actuarial losses from AOCI $ 2,398    $ —   
Total before tax 2,398    —   
Tax impact (776)   —   
Total after tax $ 1,623    $ —   
The amounts recorded in prior years in AOCI exceeding 10% of the defined benefit obligation are recorded ratably as reclassification of actuarial losses over the current year through profit and loss separately from income from operations and amounted to $2.4 million in the three months ended March 31, 2020.
Note K. Earnings Per Share
Basic EPS is calculated by dividing the profit for the year attributable to ordinary equity holders of the parent by the weighted average number of ordinary shares outstanding during the year.
Diluted EPS is calculated by dividing the profit for the year (numerator) attributable to ordinary equity holders of the parent by the weighted average number of ordinary shares outstanding during the year plus the weighted average number of ordinary shares arising from exercising all dilutive ordinary shares (denominator).
19



The following table reflects the income and share data used in the basic and diluted EPS computations:
Three Months Ended March 31,
2020 2019
Net income for the period - attributable to ordinary equity holders of the parent (in thousands) $ 18,032    $ 18,954   
Weighted average number of ordinary shares (in thousands of shares) 60,276    59,518   
Basic EPS $ 0.30    $ 0.32   
Dilutive effect of share based payments (in thousands of shares) 1,115    1,595   
Weighted average number of diluted ordinary shares (in thousands of shares) 61,391    61,113   
Diluted EPS $ 0.29    $ 0.31   
In 2019 and 2020, new shares were generated and transferred for settlement of stock based compensation, which was also included in the weighted number of shares. The dilutive effect of the share-based payment transaction is the weighted number of shares considering the grant date, forfeitures and executions during the respective fiscal years. The effect is determined by using the treasury stock method.
Note L. Income Taxes
The Company records its tax provision or benefit on an interim basis using an estimated annual effective tax rate. This rate is applied to the current period ordinary income to determine the income tax provision or benefit allocated to the interim period. Losses from jurisdictions for which no benefit can be recognized, and the income tax effects of unusual and infrequent items are excluded from the estimated annual effective tax rate and are recognized in the impacted interim period as discrete items. Valuation allowances are provided against the future tax benefits that arise from the losses in jurisdictions for which no benefit can be recognized. The estimated annual effective tax rate may be significantly impacted by nondeductible expenses and the Company’s projected earnings mix by tax jurisdiction. Adjustments to the estimated annual effective income tax rate are recognized in the period when such estimates are revised.
The development of deferred tax assets and liabilities relates to changes in temporary differences and tax loss carry forwards. Income tax receivables decreased from $17.9 million at December 31, 2019 to $7.8 million at March 31, 2020 due to tax refunds received from tax authorities. Income taxes payable increased from $14.2 million at December 31, 2019 to $14.9 million at March 31, 2020 mainly due to the current tax expense for the period ended March 31, 2020, less payments to the tax authorities.
Income tax expense for the three months ended March 31, 2020 amounted to $7.6 million compared to $9.4 million for the three months ended March 31, 2019, reflecting profit in these periods.
For the three months ended March 31, 2020, the impact of discrete tax items included a net discrete tax gain of $0.7 million and is primarily due to the refund of prior year taxes in connection with the land sale in South Korea during 2018, offset by the unfavorable deferred tax expense of $0.8 million due to the revaluation of the realizability of deferred tax assets. Therefore, the effective tax rate of 29.75% for the three months ended March 31, 2020 deviated from the estimated annual tax rate of 29.19% for 2020.
For the three months ended March 31, 2019, the impact of discrete tax items included a net discrete tax expense of $0.9 million and is primarily due to various provision adjustments related to tax return filings. Therefore the effective tax rate of 33.40%for the three months ended March 31, 2019 deviated from the estimated annual tax rate of 30.1% for 2019.

Note M. Commitments and Contingencies
Other Long-Term Commitments
To safeguard the supply of raw materials, contractual purchase commitments under long-term supply agreements for raw materials, primarily oil and gas, are in place with the following maturities:
Maturity March 31, 2020
(In thousands)
2021 $ 71,630   
2022 to 2025 61,659   
2026 and thereafter —   
Total $ 133,290   
20



Environmental Matters
EPA Action
During 2008 and 2009, the U.S. Environmental Protection Agency (“EPA”) contacted all U.S. carbon black producers as part of an industry-wide EPA initiative, requesting extensive and comprehensive information under Section 114 of the U.S. Clean Air Act. The EPA used that information to determine, for each facility, that either: (i) the facility has been in compliance with the Clean Air Act; (ii) violations have occurred and enforcement litigation may be undertaken; or (iii) violations have occurred and a settlement of an enforcement case is appropriate. In response to information requests received by the Company’s U.S. facilities, the Company furnished information to the EPA on each of its U.S. facilities. EPA subsequently sent notices under Section 113(a) of the Clean Air Act in 2010 alleging violations of Prevention of Significant Deterioration (“PSD”) and Title V permitting requirements under the Clean Air Act at the Company’s Belpre (Ohio) facility. In October 2012, the Company received a corresponding notice and finding of violation (a “NOV”) alleging the failure to obtain PSD and Title V permits reflecting Best Available Control Technology (“BACT”) at several units of the Company’s Ivanhoe (Louisiana) facility, and in January 2013 the Company also received a NOV issued by the EPA for its facility in Borger (Texas) alleging the failure to obtain PSD and Title V permits reflecting BACT during the years 1996 to 2008. A comparable NOV for the Company’s U.S. facility in Orange (Texas) was issued by the EPA in February 2013; and EPA issued an additional NOV in March 2016 alleging more recent non-PSD air emissions violations primarily at the dryers and the incinerator of the Orange facility.
In 2013, Orion began discussions with the EPA and the U.S. Department of Justice about a potential settlement to resolve the NOVs received, which ultimately led to a consent decree executed between Orion Engineered Carbons LLC (for purpose of this note M. “Orion”) and the United States (on behalf of the EPA), as well as the Louisiana Department of Environmental Quality. The consent decree (the “EPA CD”) became effective on June 7, 2018. The consent decree resolves and settles the EPA’s claims of noncompliance set forth in the NOVs and in a respective complaint filed in court against Orion by the United States immediately prior to the filing of the consent decree.
All five U.S. carbon black producers have settled with the U.S. government.
Under Orion’s EPA CD, Orion will install certain pollution control technology in order to further reduce emissions at its four U.S. manufacturing facilities in Ivanhoe (Louisiana), Belpre (Ohio), Borger (Texas), and Orange (Texas) over approximately five years. The EPA CD also requires the continuous monitoring of emissions reductions that Orion will need to comply with over a number of years. Orion has commenced the installation works for its Ivanhoe and Orange facilities. However, construction at these facilities has been subject to COVID-19-related delays, and as a result we have declared force majeure towards EPA and requested an extension of the timelines for completion of installations. Under the EPA CD, Orion can choose either its Belpre or Borger facilities as the next site for installation of pollution control equipment with comparable effectiveness. We expect the capital expenditures for installation of pollution control equipment in the remaining Orion facilities to decrease due to economies of scale and synergies from prior installations. We also expect that the third and fourth plants will require significantly less costly pollution control equipment given the requirements of the EPA CD. We estimate the installations of monitoring and pollution control equipment at all four Orion plants in the U.S. will require capital expenditures in an approximate range between $230 million to $270 million of which approximately $85 million has been spent to date. To narrow this range, the Company pursues further scope design and estimation efforts. However, the actual total capital expenditures we might need to incur in order to fulfill the requirements of the EPA CD remain uncertain. The EPA CD allows some flexibility for Orion to choose among different technology solutions for reducing emissions and the locations where these solutions are implemented. The solutions Orion ultimately chooses to implement at its facilities other than Ivanhoe (Louisiana), may differ in scope and operation from those it currently anticipates (including those discussed in the next paragraph) and, for any and all of its four facilities, factors, such as timing, locations, target levels, changing cost estimates and local regulations, could cause actual capital expenditures to exceed or be lower than current expectations or affect Orion’s ability to meet the agreed target emission levels or target dates for installing required equipment as anticipated or at all. Orion also agreed to and paid a civil penalty of $0.8 million and agreed to perform environmental mitigation projects totaling $0.6 million. Noncompliance with applicable emissions limits could lead to further penalty payments to the EPA.
As part of Orion’s compliance plan under the EPA CD, in April 2018 Orion signed a contract with Haldor Topsoe group to install its SNOXTM emissions control technology to remove SO2, NOx and dust particles from tail gases at Orion’s Ivanhoe, Louisiana Carbon Black production plant. The SNOXTM technology has not been used previously in the carbon black industry.
21



Orion’s Share Purchase Agreement with Evonik in connection with the Acquisition provides for a partial indemnity from Evonik against various exposures, including, but not limited to, capital investments, fines and costs arising in connection with Clean Air Act violations that occurred prior to July 29, 2011. Except for certain less relevant allegations contained in the second NOV received for the Company’s facility in Orange (Texas) in March 2016, all of the other allegations made by the EPA with regard to all four of the Company’s U.S. facilities - as discussed above - relate to alleged violations before July 29, 2011. The indemnity provides for a recovery from Evonik of a share of the costs (including fines), expenses (including reasonable attorney’s fees, but excluding costs for maintenance and control in the ordinary course of business and any internal cost of monitoring the remedy), liabilities, damages and losses suffered and is subject to various contractual provisions including provisions set forth in the Share Purchase Agreement with Evonik, such as a de minimis clause, a basket, overall caps (which apply to all covered exposures and all covered environmental exposures, in the aggregate), damage mitigation and cooperation requirements, as well as a statute of limitations provision. Due to the cost-sharing and cap provisions in Evonik’s indemnity, the Company expects that substantial costs it has already incurred and will incur in this EPA enforcement initiative and the EPA CD likely will exceed the scope of the indemnity in the tens of millions of US dollars. In addition, Evonik signaled that it is not honoring Orion’s claims under the indemnity. In June 2019, Orion initiated arbitration proceedings to enforce its rights against Evonik. Evonik in turn has submitted certain counterclaims related to a tax indemnity and cost reimbursement against Orion, which counterclaims we do not believe to be material. Although Orion believes that it is entitled to the indemnity and that its rights thereunder are enforceable, there is no assurance that the Company will be able to recover costs or expenditures incurred under the indemnity as it expects or at all.
Pledges and guarantees
The Company has pledged the majority of its assets (amongst others shares in affiliates, bank accounts and receivables) within the different regions excluding China serving as collateral under the credit agreement dated July 25, 2014 as amended from time to time. As of March 31, 2020 the principal amounts of the outstanding term loans under the Credit Agreement were $280.4 million (U.S. Dollar Term Loan), and €351.7 million (Euro Term Loan) while the amount drawn under the revolving credit facility was $43.8 million.
As at March 31, 2020 Orion Engineered Carbons GmbH had five guarantees issued by Euler Hermes S.A. with a total volume of $9.4 million (as at December 31, 2019 three guarantees by Euler Hermes S.A. of $9.2 million); one guarantee insurance issued by Deutsche Bank AG with a volume of $2.2 million (one guarantee issued by Deutsche Bank AG with a volume of $2.2 million as at December 31, 2019). None of these guarantees reduce the possible utilization limit of the current RCF.
Note N. Financial Information by Segment
Segment information
The Company’s business is organized by its two carbon black product types. For corporate management purposes and all periods presented the Company had Rubber Carbon Black and Specialty Carbon Black as reportable operating segments. Rubber carbon black is used in the reinforcement of rubber in tires and mechanical rubber goods, Specialties are used as pigments and performance additives in coatings, polymers, printing and special applications.
The following table shows the percent of revenue recognized in each of the Company’s reportable segment:
Three Months Ended March 31,
2020 2019
Rubber    64  % 66  %
Specialty    36  % 34  %
The senior management team, which is composed of the CEO, CFO and certain other senior management members is the chief operating decision maker (“CODM”). The senior management team monitors the operating segments’ results separately in order to facilitate decisions regarding the allocation of resources and determine the segments’ performance. Orion uses Adjusted EBITDA as the segments' performance measure. The CODM does not review reportable segment asset or liability information for purposes of assessing performance or allocating resources.
Adjustment items are not allocated to the individual segments as they are managed on a group basis.
22



Segment reconciliation for the three months ended March 31, 2020 and 2019:
Rubber Specialties Corporate Total segments
(In thousands)
2020
Net sales from external customers $ 216,228    $ 119,779    $ —    $ 336,007   
Adjusted EBITDA $ 35,768    $ 28,076    $ —    $ 63,844   
Corporate charges —    —    (2,323)   (2,323)  
Depreciation and amortization of intangible assets and property, plant and equipment (15,293)   (8,552)   —    (23,845)  
Excluding equity in earnings of affiliated companies, net of tax (133)   —    —    (133)  
Income from operations before income tax expense and finance costs 20,342    19,524    (2,323)   37,543   
Interest and other financial expense, net —    —    (9,610)   (9,610)  
Reclassification of actuarial losses from AOCI —    —    (2,398)   (2,398)  
Income tax expense —    —    (7,635)   (7,635)  
Equity in earnings of affiliated companies, net of tax 133    —    —    133   
Net income $ 18,032   
2019
Net sales from external customers $ 253,128    $ 131,586    $ —    $ 384,714   
Adjusted EBITDA $ 35,165    $ 29,402    $ —    $ 64,567   
Corporate charges —    —    (5,636)   (5,636)  
Depreciation and amortization of intangible assets and property, plant and equipment (13,765)   (10,330)   —    (24,095)  
Excluding equity in earnings of affiliated companies, net of tax (137)   —    —    (137)  
Income from operations before income tax expense and finance costs 21,263    19,072    (5,636)   34,699   
Interest and other financial expense, net —    —    (6,443)   (6,443)  
Reclassification of actuarial losses from AOCI —    —    —    —   
Income tax expense —    —    (9,439)   (9,439)  
Equity in earnings of affiliated companies, net of tax 137    —    —    137   
Net income $ 18,954   
The sales information noted above relates to external customers only. ‘Corporate and other’ includes income and expense that cannot be directly allocated to the business segments or are managed on corporate level and includes finance income and expenses, taxes and items with less bearing on the underlying core business.
Income from operations before income taxes and finance costs of the segment 'Corporate and other' comprises the following:
Three Months Ended March 31,
2020 2019
(In thousands)
Restructuring expenses/(income) $ —    $ 89   
Consulting fees related to Company strategy —    916   
Long Term Incentive Plan (1,139)   3,553   
EPA-related expense 2,589    718   
Other non-operating 873    360   
Expense from operations before income taxes and finance costs $ 2,323    $ 5,636   

Note O. Related Parties 
As of March 31, 2020 related parties include one associate of Orion that is accounted for using the equity method, namely "Deutsche Gasrusswerke" (DGW) and one principal owner of more than 10%.
Related parties include key management personnel having authority and responsibility for planning, directing and monitoring the activities of the Company directly or indirectly and their close family members.
23



In the normal course of business Orion from time to time receives services from, or sells products to, related unconsolidated parties, in transactions that are either not material or approved in accordance with our Related Party Transaction Approval Policy.
March 31, 2020 December 31, 2019
(In thousands)
Trade receivables from DGW KG $ 773    $ 522   
Trade payables to DGW KG $ 13,895    $ 17,871   

Three Months Ended March 31,
2020 2019
(In thousands)
Purchased carbon black products from DGW KG    $ 21,322    $ 22,765   
Sales and services provided to DGW KG    $ 634    $ 663   

24



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis summarizes the significant factors affecting our results of operations and financial condition during the three months ended March 31, 2020 and 2019 and should be read in conjunction with the information included under Item 1. Financial Statements and Supplementary Data (unaudited) included elsewhere in this report. We prepare our financial statements in accordance with accounting principles generally accepted in the United States.

PRESENTATION OF CERTAIN FINANCIAL AND OTHER INFORMATION

Non-GAAP Financial Measures
In this report, we present certain financial measures that are not recognized by GAAP and that may not be permitted to appear on the face of GAAP-compliant financial statements or notes thereto. The non-GAAP financial measures contained in this report are unaudited and have not been prepared in accordance with GAAP or the accounting standards of any other jurisdiction and may not be comparable to other similarly titled measures of other companies. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures, see below.
The non-GAAP financial measures used in this report are Contribution Margin, Contribution Margin per Metric Ton (collectively, “Contribution Margins”), Adjusted EBITDA, Net Working Capital and Capital Expenditures. We define Contribution Margin as revenue less variable costs (such as raw materials, packaging, utilities and distribution costs). We define Contribution Margin per Metric Ton as Contribution Margin divided by volume measured in metric tons. We define Adjusted EBITDA as operating result (EBIT) before depreciation and amortization, adjusted for acquisition related expenses, restructuring expenses, consulting fees related to Company strategy, share of profit or loss of joint venture and certain other items. Adjusted EBITDA is defined similarly in the Credit Agreement. Adjusted EBITDA is used by our management to evaluate our operating performance and make decisions regarding allocation of capital because it excludes the effects of items that have less bearing on the performance of our underlying core business. We define Net Working Capital as inventories plus current trade receivables minus trade payables. We define Capital Expenditures as cash paid for the acquisition of intangible assets and property, plant and equipment as shown in the consolidated financial statements.
We also use Segment Adjusted EBITDA Margin, which we define as Adjusted EBITDA for the relevant segment divided by the revenue for that segment.
We use Adjusted EBITDA, Contribution Margins and Net Working Capital, as well as Adjusted EBITDA by segment and Segment Adjusted EBITDA Margin, as internal measures of performance to benchmark and compare performance among our own operations. We use these measures, together with other measures of performance under GAAP, to compare the relative performance of operations in planning, budgeting and reviewing the performance of our business. We believe these measures are useful measures of financial performance in addition to consolidated net income for the period, income from operations (EBIT) and other profitability measures under GAAP because they facilitate operating performance comparisons from period to period and company to company and, with respect to Contribution Margin, eliminate volatility in feedstock prices. By eliminating potential differences in results of operations between periods or companies caused by factors such as depreciation and amortization methods, historic cost and age of assets, financing and capital structures and taxation positions or regimes, we believe that Adjusted EBITDA can provide a useful additional basis for comparing the current performance of the underlying operations being evaluated. For these reasons, we believe EBITDA-based measures are often used by the investment community as a means of comparison of companies in our industry. By deducting variable costs (such as raw materials, packaging, utilities and distribution costs) from revenue, we believe that Contribution Margins can provide a useful basis for comparing the current performance of the underlying operations being evaluated by indicating the portion of revenue that is not consumed by these variable costs and therefore contributes to the coverage of all costs and profits.
Different companies and analysts may calculate measures based on EBITDA, contribution margins and working capital differently, so making comparisons among companies on this basis should be done carefully. Adjusted EBITDA, Contribution Margins and Net Working Capital are not measures of performance under GAAP and should not be considered in isolation or construed as substitutes for revenue, consolidated net income for the period, income from operations (EBIT), gross profit and other GAAP measures as an indicator of our operations in accordance with GAAP.
Reconciliation of Non-GAAP Financial Measures
We use Contribution Margin and Adjusted EBITDA as supplemental measures of our operating performance. Contribution Margin and Adjusted EBITDA presented in this Management Discussion and Analysis have not been prepared in accordance with GAAP or the accounting standards of any other jurisdiction. Other companies may use similar non-GAAP financial measures that are calculated differently from the way we calculate these measures. Accordingly, our Contribution Margin and Adjusted EBITDA may not be comparable to similar measures used by other companies and should not be considered in isolation, or construed as substitutes for, revenue, consolidated net income for the period, income from operations (EBIT), gross profit and other GAAP measures as indicators of our results of operations in accordance with GAAP.
25



Contribution Margin and Contribution Margin per Metric Ton (Non-GAAP Financial Measures)

We calculate Contribution Margin by subtracting variable costs (such as raw materials, packaging, utilities and distribution costs) from our revenue. We believe that Contribution Margin is useful because we see this measure as indicating the portion of revenue that is not consumed by such variable costs and therefore contributes to the coverage of all other costs and profits. The following table reconciles Contribution Margin and Contribution Margin per Metric Ton to gross profit:
Three Months Ended March 31,
2020 2019
unaudited
(in millions, unless otherwise indicated)
Revenue(1)
$ 336.0    $ 384.7   
Variable costs(2)
(204.1)   (248.4)  
Contribution margin 131.9    136.3   
Freight 19.2    21.2   
Fixed Costs(3)
(60.8)   (59.5)  
Gross profit (1)
$ 90.2    $ 98.0   
Volume (in kmt) 235.1    262.8   
Contribution margin per metric ton $ 560.8    $ 518.7   
Gross profit per metric ton $ 383.6    $ 372.8   
(1) Separate line item in Condensed Consolidated Financial Statements.

(2) Includes costs such as raw materials, packaging, utilities and distribution.

(3) Includes costs such as depreciation, amortization and impairment of intangible assets and property, plant and equipment,
personnel and other production related costs.
Adjusted EBITDA (Non-GAAP Financial Measure)
We define Adjusted EBITDA as income from operations (EBIT) before depreciation and amortization, adjusted for acquisition related expenses, restructuring expenses, consulting fees related to Company strategy, share of profit or loss of joint venture and certain other items. Adjusted EBITDA is defined similarly in our Credit Agreements. Adjusted EBITDA is used by our management to evaluate our operating performance and make decisions regarding allocation of capital because it excludes the effects of items that have less bearing on the performance of our underlying core business.
Our use of Adjusted EBITDA has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our financial results as reported under GAAP. Some of these limitations are: (a) although Adjusted EBITDA excludes the impact of depreciation and amortization, the assets being depreciated and amortized may have to be replaced in the future and thus the cost of replacing assets or acquiring new assets, which will affect our operating results over time, is not reflected; (b) Adjusted EBITDA does not reflect interest or certain other costs that we will continue to incur over time and will adversely affect our profit or loss, which is the ultimate measure of our financial performance and (c) other companies, including companies in our industry, may calculate Adjusted EBITDA or similarly titled measures differently. Because of these and other limitations, Adjusted EBITDA should be considered alongside our other GAAP-based financial performance measures, such as revenue, consolidated net income for the period or income from operations (EBIT).

26



The following table presents a reconciliation of Adjusted EBITDA to consolidated net income for each of the periods indicated:
Three Months Ended March 31,
2020 2019
(in $ millions)
Net income $ 18.0    $ 19.0   
Add back income tax expense 7.6    9.4   
Add back equity in earnings of affiliated companies, net of tax (0.1)   (0.1)  
Income from operations before income taxes and equity in earnings of affiliated companies 25.5    28.3   
Add back interest and other financial expense, net 9.6    6.4   
Reclassification of actuarial losses from AOCI 2.4    —   
Earnings before income taxes and finance income/costs 37.5    34.7   
Add back depreciation, amortization and impairment of intangible assets and property, plant and equipment 23.8    24.1   
EBITDA 61.4    58.8   
Equity in earnings of affiliated companies, net of tax 0.1    0.1   
Restructuring expenses/(income) (1)
—    0.1   
Consulting fees related to Company strategy (2)
—    0.9   
Long term incentive plan (1.1)   3.6   
EPA-related expenses 2.6    0.7   
Other adjustments (3)
0.9    0.4   
Adjusted EBITDA $ 63.8    $ 64.6   
Thereof Adjusted EBITDA Specialty Carbon Black
$ 28.1    $ 29.4   
Thereof Adjusted EBITDA Rubber Carbon Black
$ 35.8    $ 35.2   
(1) Restructuring expenses for the three months ended March 31, 2019 are related to our strategic realignment of our worldwide Rubber footprint.
(2) Consulting fees related to the Orion strategy include external consulting for establishing and executing Company strategies relating to Rubber footprint realignment, conversion to U.S. dollar and U.S. GAAP, as well as costs relating to our assessment of feasibility for inclusion in certain U.S. indices.
(3) Other adjustments in the three months ended March 31, 2020 mainly relate to a non-income tax expense incurred during the construction phase of an asset in an amount of $0.3 million. The asset under construction is expected to qualify for certain non-income tax credits once operational, since such credits were applied to the predecessor machine. This tax disadvantage cannot be capitalized as part of the project’s capital expenditure.
27



Operating Results
2020 Compared to 2019
The table below presents our historical results derived from our consolidated financial statements for the periods indicated.  
Statement of operations data Three Months Ended March 31,
2020 2019
(In millions)
Net sales $ 336.0    $ 384.7   
Cost of sales 245.8    286.7   
Gross profit 90.2 98.0
Selling, general and administrative expenses 44.5    55.6   
Research and development costs 5.0    5.1   
Other expenses, net 3.2    2.5   
Restructuring expenses —    0.1   
Income from operations 37.5 34.7
Interest and other financial expense, net 9.6    6.4   
Reclassification of actuarial losses from AOCI 2.4    —   
Income from operations before income tax expense and equity in earnings of affiliated companies 25.5 28.3
Income tax expense 7.6    9.4   
Equity in earnings of affiliated companies, net of tax 0.1    0.1   
Net income $ 18.0    $ 19.0   
Net sales
Net sales decreased overall by $48.7 million, or 12.7%, from $384.7 million in the three months ended March 31, 2019 to $336.0 million in the three months ended March 31, 2020 driven by lower volumes, passing on lower feedstock costs to customers and negative foreign exchange rate translation effects, partially offset by favorable product mix and positive base price increases.
Volume decreased by 27.7 kmt, or 10.5%, from 262.8 kmt in the three months ended March 31, 2019 to 235.1 kmt in the three months ended March 31, 2020, principally reflecting the impact on the Rubber and Specialties segments of a sharp reduction in sales volume beginning in mid-March as tire manufacturing plants began idling or closing outright in anticipation of the negative implications of the COVID-19 pandemic on miles driven and light vehicle sales. Lower volumes also reflected the impact of a deliberate Rubber commercial strategy as part of 2019 contract negotiations to emphasize raising price closer to reinvestment levels over volume.
Cost of sales and Gross profit
Cost of sales decreased by $40.9 million, or 14.3%, from $286.7 million in the three months ended March 31, 2019 to $245.8 million in the three months ended March 31, 2020. The 10.5% decrease in volume in the three months ended March 31, 2020 compared to the three months ended March 31, 2019 resulted in a decrease of cost of sales of 10.6%, or $26.0 million in the three months ended March 31, 2020 compared to the three months ended March 31, 2019 while the remaining decrease is primarily related to changes in oil prices.
As a result, gross profit decreased by $7.8 million, or 7.9%, from $98.0 million in the three months ended March 31, 2019 to $90.2 million in the three months ended March 31, 2020 for reasons described above.
Selling, general and administrative expenses
Selling, general and administrative expenses decreased by $11.1 million, or 19.9%, from $55.6 million in the three months ended March 31, 2019 to $44.5 million in the three months ended March 31, 2020 primarily due to lower personnel related expenses related to bonuses including long term incentive expenses, lower distribution expenses as a result of lower volumes and favorable impacts from foreign currency translation impacts.
Research and development costs
R&D expenses decreased by $0.2 million, from $5.1 million in the three months ended March 31, 2019 to $5.0 million in the three months ended March 31, 2020. This decrease is primarily related to the timing of expenditures for individual development of programs.
28



Other expenses, net
Other expenses, net which comprises other operating income and other operating expenses, amounted to $3.2 million in the three months ended March 31, 2020 and $2.5 million in the three months ended March 31, 2019.
In the three months ended March 31, 2020, other operating income amounted to $2.0 million and included, among other items, a gain related to the release of bonus accruals. Other operating expenses in the three months ended March 31, 2020 amounted to $5.2 million, comprised primarily of $2.6 million EPA-related expenses and impairment and write-off charges of $0.9 million.
In the three months ended March 31, 2019, other operating income amounted to $0.2 million. Other operating expenses in the three months ended March 31, 2019 amounted to $2.7 million, comprised primarily of $0.9 million consulting fees related to Company strategy and EPA-related expenses of $0.7 million.
Restructuring expenses/(income), net
In the three months ended March 31, 2019, restructuring expenses related to the strategic repositioning of the Rubber business footprint amounted to $0.1 million, Our Rubber footprint restructuring activities in the fiscal years 2016 to 2019 generated annualized savings of approximately $16 million per year on a consolidated basis since the end of fiscal year 2018 from the facility shutdown in Ambès, France, the facility consolidations in Seoul, South Korea, the related headcount reductions, as well as to a lesser extent, to operational efficiencies. These anticipated savings were expected to come essentially in full from our reportable Rubber segment. Besides the realized one-time gain recorded upon the sale of our land in Seoul, South Korea, a significant portion of the anticipated savings are expected to be reinvested in business development, research & development and capital improvements to help drive organic growth.
Income from operations
Income from operations increased by $2.8 million, or 8.2%, from $34.7 million in the three months ended March 31, 2019 to $37.5 million in the three months ended March 31, 2020. Lower gross profit was more than offset by lower selling, general and administration expenses as described above. The decrease in selling, general and administrative expenses was primarily attributable to lower bonus charges year over year including releases of long term incentive expenses.
Interest and other financial expense, net
Interest and other financial expense, net comprises interest and other financial income and interest and other financial expenses. Interest and other financial expense, net amounted to $9.6 million in the three months ended March 31, 2020 compared to $6.4 million in the three months ended March 31, 2019.
Interest and other financial expense, net in the three months ended March 31, 2020 includes, among others, $3.6 million of regular interest expenses for our term loan facilities, $0.5 million of amortization of capitalized transaction costs and $5.2 million net expenses of foreign currency revaluation effects.
Interest and other financial expense, net in the three months ended March 31, 2019 includes regular interest expenses for our term loan facilities amortization of capitalized transaction costs and $1.4 million net gains of foreign currency revaluation effects.
Reclassification of actuarial losses from AOCI
The actuarial losses associated with our pension obligations recorded in prior years in accumulated other comprehensive income exceeding 10% of the defined benefit obligation are recorded ratably over the current year through profit and loss separately from income from operations and amounted to $2.4 million in the three months ended March 31, 2020.
Income from operations before income tax expense and equity in earnings of affiliated companies
Income from operations before income tax expense and equity in earnings of affiliated companies decreased by $2.7 million, or 9.6%, from $28.3 million in the three months ended March 31, 2019 to $25.5 million in the three months ended March 31, 2020, as a result of the effects described above.
Income tax expense
Income tax expense amounted to $7.6 million in the three months ended March 31, 2020 compared to $9.4 million in the three months ended March 31, 2019, as a result of decreased income before taxes.
In the three months ended March 31, 2020, the effective tax rate of 29.7% included a net discrete tax gain of $0.7 million and deviated therefore from the estimated annual tax rate of 29.19%. For details regarding this deviation see Note L. Income Taxes to the unaudited condensed consolidated financial statements.
29



In the three months ended March 31, 2019, the effective tax rate of 33.2% deviated from out estimated annual effective tax rate of 30.1% in particular due to a net discrete tax expense of $0.9 million. For details regarding this deviation see Note L. Income Taxes to the unaudited condensed consolidated financial statements.
Equity in earnings of affiliated companies, net of tax
Equity in earnings of affiliated companies represents the equity income from our German JV, which was comparable in the three months ended March 31, 2020 and the three months ended March 31, 2019.
Net income
Our net income in the three months ended March 31, 2020 amounted to $18.0 million, a decrease of $0.9 million, reflecting all the factors described above.
Contribution Margin and Contribution Margin per Metric Ton (Non-GAAP Financial Measures)
Contribution Margin decreased by $4.4 million, or 3.3%, from $136.3 million in the three months ended March 31, 2019 to $131.9 million in the three months ended March 31, 2020, primarily due to lower volumes and negative foreign exchange rate translation effects partially offset by favorable base price increases in the Rubber segment in particular and a favorable product mix in the Specialty segment in particular. Contribution Margin per Metric Ton increased by 8.1%, from $518.7 per Metric Ton in the three months ended March 31, 2019 to $560.8 per Metric Ton in the three months ended March 31, 2020.
Adjusted EBITDA (Non-GAAP Financial Measure)
Adjusted EBITDA decreased by $0.7 million, or 1.1%, from $64.6 million in the three months ended March 31, 2019 to $63.8 million in the three months ended March 31, 2020 mainly reflecting lower contribution margins and higher fixed costs of sales offset by lower selling and administrative expenses and positive foreign exchange translation effects on fixed costs.
2019 Compared to 2018
The comparison of the three months ended March 31, 2019and the three months ended March 31, 2018 can be found in our quarterly report filed as Exhibit to Form 6-K for the three months ended March 31, 2019 located within “Part I, Item 2. Management’s Discussions and Analysis — Operating Results”, which is incorporated by reference herein.
Segment Discussion
Our business operations are divided into two operating segments: the Specialty Carbon Black segment and the Rubber Carbon Black segment. We use segment revenue, segment gross profit, segment volume, Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin as measures of segment performance and profitability.
30



The table below presents our segment results derived from our audited consolidated financial statements for the periods indicated.
Three Months Ended March 31,
2020 2019
(In millions, unless otherwise indicated)
Specialty Carbon Black
Net sales $ 119.8    $ 131.6   
Cost of sales (80.0)   (90.2)  
Gross profit $ 39.7    $ 41.4   
Volume (kmt) 58.3    64.0   
Adjusted EBITDA $ 28.1    $ 29.4   
Adjusted EBITDA Margin (%)(1)
23.4    22.3   
Rubber Carbon Black
Net sales $ 216.2    $ 253.1   
Cost of sales (165.8)   (196.6)  
Gross profit $ 50.5    $ 56.6   
Volume (kmt) 176.8    198.8   
Adjusted EBITDA $ 35.8    $ 35.2   
Adjusted EBITDA Margin (%)(1)
16.5    13.9   
(1) Defined as Adjusted EBITDA divided by net sales.
Specialty Carbon Black
2020 Compared to 2019
Net sales of the Specialty Carbon Black segment decreased by $11.8 million, or 9.0%, from $131.6 million in the three months ended March 31, 2019 to $119.8 million in the three months ended March 31, 2020, primarily due to lower volumes and the pass through of lower feedstock costs to customers, partially offset by favorable product mix and base price increases.
Volume of the Specialty Carbon Black segment decreased by 5.6 kmt, or 8.8%, from 64.0 kmt in the three months ended March 31, 2019 to 58.3 kmt in the three months ended March 31, 2020, mainly due to weakening demand in the North America and Western Europe regions predominantly in the automotive and pipe markets.
Gross profit of the Specialty Carbon Black segment decreased by $1.7 million, or 4.0%, from $41.4 million in the three months ended March 31, 2019 to $39.7 million in the three months ended March 31, 2020, mainly due to lower volumes and negative foreign exchange rate translation effects partially offset by higher base price and favorable mix.
Adjusted EBITDA of the Specialty Carbon Black segment decreased by $1.3 million, or 4.5%, from $29.4 million in the three months ended March 31, 2019 to $28.1 million in the three months ended March 31, 2020, primarily driven by the factors driving lower Gross Profit. Adjusted EBITDA margin increased 110 basis points to 23.4% compared to 22.3% in the first quarter of 2019.
2019 Compared to 2018
The comparison of the three months ended March 31, 2019 and the three months ended March 31, 2018 can be found in our quarterly report filed as Exhibit to Form 6-K for the three months ended March 31, 2019 located within “Part I, Item 2. Management’s Discussions and Analysis — Operating Results”, which is incorporated by reference herein.
Rubber Carbon Black
2020 Compared to 2019
Net sales of the Rubber Carbon Black segment decreased by $36.9 million, or 14.6%, from $253.1 million in the three months ended March 31, 2019 to $216.2 million in the three months ended March 31, 2020, primarily due to lower volumes and passing through lower feedstock costs to customers partially offset by base price increases.
Volume of the Rubber Carbon Black segment decreased by 22.0 kmt, or 11.1%, from 198.8 kmt in the three months ended March
31



31, 2019 to 176.8 kmt in the three months ended March 31, 2020 primarily attributable to a sharp decline in sales volumes beginning in mid-March as tire and auto manufacturing plants closed due to COVID-19. Lower volumes also reflected the impact of a deliberate Rubber commercial strategy as part of 2019 contract negotiations to emphasize raising price closer to reinvestment levels over volume.
Gross profit of the Rubber Carbon Black segment decreased by $6.1 million, or 10.8%, from $56.6 million in the three months ended March 31, 2019 to $50.5 million in the three months ended March 31, 2020 as a result of lower volumes and negative foreign exchange translation offset in part by base price increases and favorable absorption due to inventory build.
Adjusted EBITDA of the Rubber Carbon Black segment increased by $0.6 million, or 1.7%, from $35.2 million in the three months ended March 31, 2019 to $35.8 million in the three months ended March 31, 2020, reflecting higher base prices and favorable absorption partially offset by lower volumes. Adjusted EBITDA margin was 16.5% in the first quarter of 2020 compared to 13.9% in the first quarter of 2019.
2019 Compared to 2018
The comparison of the three months ended March 31, 2019 and the three months ended March 31, 2018 can be found in our quarterly report filed as Exhibit to Form 6-K for the three months ended March 31, 2019 located within “Part I, Item 2. Management’s Discussions and Analysis — Operating Results”, which is incorporated by reference herein.
Liquidity and Capital Resources
Historical Cash Flows
The tables below present our historical cash flows derived from our unaudited consolidated financial statements for the periods indicated.
Three Months Ended March 31,
2020 2019
(In millions)
Net cash provided by operating activities $ 4.9    $ 26.2   
Net cash used in investing activities $ (50.9)   $ (22.5)  
Net cash provided by (used in) financing activities $ 94.6    $ 0.3   
Cash, cash equivalents and restricted cash at the end of the period $ 110.2    $ 65.4   
Less restricted cash at the end of the period 2.7    4.5   
Cash and cash equivalents at the end of the period $ 107.5    $ 60.9   
2020
Net cash provided by operating activities in the three months ended March 31, 2020 amounted to $4.9 million and consisted of a consolidated profit for the period of $18.0 million, adjustments primarily for depreciation of $23.8 million and cash outflows from changes in operating assets and liabilities of $38.4 million basically related to changes in Net Working Capital.
Net cash used in investing activities in the three months ended March 31, 2020 amounted to $50.9 million comprised of $28.2 million capital expenditure for maintenance and overhaul projects and expenditures associated as well as $22.7 million environmental improvements of our U.S. based facilities to address the EPA requirements.
Net cash provided by financing activities in the three months ended March 31, 2020 amounted to $94.6 million. Cash inflows during the quarter of $109.8 million are related to local bank loan facilities to bolster the liquidity of the Company in light of the current COVID-19 uncertainties while cash outflows were used for regular debt repayment of $2.0 million and $12.0 million dividend payments.
2019
Net cash provided by operating activities in the three months ended March 31, 2019 amounted to $26.2 million and consisted of a consolidated profit for the period of $19.0 million, adjustments primarily for depreciation of $24.1 million and from changes in operating assets and liabilities of $20.0 million of which outflows from Net Working Capital amounted to $0.8 million.
Net cash used in investing activities in the three months ended March 31, 2019 amounted to $22.5 million. It comprises capital expenditure projects mainly related to preservation and overhaul projects as well as expenditures associated with our efforts to meet the EPA requirements in the U.S.

32



Net cash provided by financing activities in the three months ended March 31, 2019 amounted to $0.3 million. $22.8 million was used for repayments of current borrowing, $2.0 million for regular debt repayments and $11.9 million for dividend payments. Cash inflows of $37.1 million are related to local short term financing facilities.
Sources of Liquidity

Our principal sources of liquidity are the net cash generated (i) from operating activities, primarily driven by our operating results and changes in working capital requirements, and (ii) from financing activities, primarily driven by, borrowing amounts available under our committed multicurrency, senior secured Revolving Credit Facility, and related ancillary facilities as well as various uncommitted local credit lines and, from time to time, term loan borrowings.
While we continue to closely monitor our working capital management and capital spending in light of continuing uncertainties in the global economy, we anticipate that cash on hand and cash provided by operating activities and borrowings will be sufficient to pay our operating expenses, satisfy debt service obligations and fund any capital expenditures for the foreseeable future.
Net Working Capital (Non-GAAP Financial Measure)
We define Net Working Capital as the total of inventories and current trade receivables, less trade payables. Net Working Capital is a non-GAAP financial measure, and other companies may use a similarly titled financial measure that is calculated differently from the way we calculate Net Working Capital. The following tables set forth the principal components of our Net Working Capital as of the dates indicated.
March 31, 2020 December 31, 2019
(In millions)
Inventories $ 168.5    $ 164.8   
Trade receivables 234.5    212.6   
Trade payables (145.3)   (156.3)  
Net working capital $ 257.7    $ 221.1   
Our Net Working Capital position can vary significantly from month to month, mainly due to fluctuations in oil prices and receipts of carbon black oil shipments. In general, increases in the cost of raw materials lead to an increase in our Net Working Capital requirements, as our inventories and trade receivables increase as a result of higher carbon black oil prices and related sales levels. These increases are partially offset by related increases in trade payables. Due to the quantity of carbon black oil that we typically keep in stock, such increases in Net Working Capital occur gradually over a period of two to three months. Conversely, decreases in the cost of raw materials lead to a decrease in our Net Working Capital requirements over the same period of time. Based on 2020 Net Working Capital requirements and normalized business activities, we estimate that a $10 per barrel movement in the Brent crude oil price correlates to a movement in our Net Working Capital of approximately $27 million to $30 million within about a two to three month period. In times of relatively stable oil prices, the effects on our Net Working Capital levels are less significant and Net Working Capital swings increase in an environment of high price volatility.
Our Net Working Capital increased from $221.1 million as of December 31, 2019 to $257.7 million as of March 31, 2020, primarily due to the timing of the impact from oil-price related pass-through effects on our accounts receivables during the quarter.
Capital Expenditures (Non-GAAP Financial Measure)
We define Capital Expenditures as cash paid for the acquisition of intangible assets and property, plant and equipment as shown in the consolidated financial statements.
Our Capital Expenditures amounted to $22.5 million in the three months ended March 31, 2019 and $50.9 million in the three months ended March 31, 2020. We plan to finance our Capital Expenditures, including the EPA related expenditure, with cash generated by our operating activities. With the exception of required expenditures in association with our settlement with the EPA we currently do not have any material commitments to make Capital Expenditures, and do not plan to make Capital Expenditures, outside the ordinary course of our business. See “Note M. Commitments and Contingencies” for further details regarding the EPA settlement.
Capital Expenditures in the three months ended March 31, 2020 amounted to $50.9 million and were mainly composed of maintenance and overhaul projects including $22.7 million expenditures associated with our efforts to commencing environmental investments required to address the EPA requirements in the United States.
Capital Expenditures in the three months ended March 31, 2019 amounted to $22.5 million and were mainly composed of preservation and overhaul projects as well as expenditures associated with our efforts for investments required to address the EPA requirements in the United States.
33




Contractual Obligations
The following table sets forth our contractual obligations as of March 31, 2020:
  Less than 1 year 1-3 years 4-5 years More than 5 years Total
In million
Long-term debt obligations(1)
$ 165.2    $ 51.5    $ 646.3    $ —    $ 724.7   
Revolving credit facility(2)
138.3    —    —    —    —   
Term loan(3)
8.1    16.1    618.9    —    643.1   
Interest expense on long-term debt(4)
18.8    35.3    27.4    —    81.6   
Purchase commitments(5)
71.6    61.7    —    —    133.3   
Operating leases 8.6    13.7    9.9    4.6    36.8   
Total contractual obligations(6)
$ 245.4    $ 126.8    $ 656.2    $ 4.6    $ 894.7   
(1)Sets forth obligations to repay principal and interest under our long-term debt obligations.
(2)Represents the obligation under the Revolving Credit Facility. As of March 31, 2020, total drawing amounting to $138.3 million either through our Revolving Credit Facility or related ancillary facilities. The Revolving Credit Facility can be drawn up to a total amount of €250.0 million (USD equivalent: $273.9 million).
(3)Represents the Term Loans and includes the outstanding principal amounts of $280.4 million (U.S. Dollar term loan) and $351.7 million (EUR term loan) which has been translated at an exchange rate at the reporting date of $1.0956 per €1.00. The borrowing costs on the principal of the Euro-denominated Term Loan have been translated applying the same exchange rate.
(4)Represents interest expenses related to indebtedness from our Term Loans, assuming future interest based on a forward rate assumption.
(5)Represents purchase commitments under long-term supply agreements for the supply of raw materials, mainly oil and gas.
(6)This amount does not reflect the Company’s obligations under its existing pension arrangements, which as of March 31, 2020 amounted to $69.5 million (see “Note G. Employee Benefit Plans with regard to pension provisions and post-retirement benefits included in the unaudited financial statements).
The level of performance bonds, guarantees and letters of credit required for carbon black oil purchasing could increase as a result of increasing oil prices or other factors (such as our ownership structure). As at March 31, 2020 Orion Engineered Carbons GmbH has five guarantees issued by Euler Hermes S.A. with a total volume of $9.4 million (in prior year three guarantees by Euler Hermes S.A. of $9.2 million); one guarantee insurance issued by Deutsche Bank AG with a volume of $2.2 million (in prior year one guarantee issued by Deutsche Bank AG with a volume of $2.2 million). None of these guarantees reduce the possible utilization limit of the current RCF.
Off-Balance Sheet Arrangements
As of March 31, 2020, we did not have any off-balance sheet arrangements.
Note Regarding Forward-Looking Statements
This report contains and refers to certain forward-looking statements with respect to our financial condition, results of operations and business. These statements constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among others, statements concerning the potential exposure to market risks, statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions and statements that are not limited to statements of historical or present facts or conditions.
Forward-looking statements are typically identified by words such as “anticipate,” “assume,” “assure” “believe,” “confident,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “objectives,” “outlook,” “probably,” “project,” “will,” “seek,” “target,” “to be,” and other words of similar meaning. These forward-looking statements include, without limitation, statements about the following matters: 
our strategies for (i) mitigating the impacts of the global outbreak of the coronavirus, (ii) strengthening our position in specialty carbon blacks and rubber carbon blacks, (ii) strengthening our position in specialty carbon blacks and rubber carbon blacks, (iii) increasing our rubber carbon black margins and (iv) strengthening the competitiveness of our operations;
34



the ability to pay dividends at historical dividend levels or at all;
cash flow projections;
the installation of pollution control technology in our U.S. manufacturing facilities pursuant to the EPA consent decree described herein;
the outcome of any in-progress, pending or possible litigation or regulatory proceedings; and
our expectation that the markets we serve will continue to grow.
All these forward-looking statements are based on estimates and assumptions that, although believed to be reasonable, are inherently uncertain. Therefore, undue reliance should not be placed upon any forward-looking statements. There are important factors that could cause actual results to differ materially from those contemplated by such forward-looking statements. These factors include, among others:
the effects of the COVID-19 pandemic on our business and results of operations;
negative or uncertain worldwide economic conditions;
volatility and cyclicality in the industries in which we operate;
operational risks inherent in chemicals manufacturing, including disruptions as a result of severe weather conditions and natural disasters;
our dependence on major customers and suppliers;
our ability to compete in the industries and markets in which we operate;
our ability to address changes in the nature of future transportation and mobility concepts which may impact our customers and our business
our ability to develop new products and technologies successfully and the availability of substitutes for our products;
our ability to implement our business strategies;
volatility in the costs and availability of raw materials (including but not limited to any and all effects from restrictions imposed by the MARPOL convention and respective International Maritime Organization (IMO) regulations in particular to reduce sulfur oxides (SOx) emissions from ships) and energy;
our ability to respond to changes in feedstock prices and quality;
our ability to realize benefits from investments, joint ventures, acquisitions or alliances;
our ability to realize benefits from planned plant capacity expansions and site development projects and the potential delays to such expansions and projects;
information technology systems failures, network disruptions and breaches of data security;
our relationships with our workforce, including negotiations with labor unions, strikes and work stoppages;
our ability to recruit or retain key management and personnel;
our exposure to political or country risks inherent in doing business in some countries;
geopolitical events in the European Union, and in particular the ultimate future relations between the European Union and the United Kingdom resulting from the “Brexit” which may impact the Euro;
environmental, health and safety regulations, including nanomaterial and greenhouse gas emissions regulations, and the related costs of maintaining compliance and addressing liabilities;
possible future investigations and enforcement actions by governmental or supranational agencies;
35



our operations as a company in the chemical sector, including the related risks of leaks, fires and toxic releases;
market and regulatory changes that may affect our ability to sell or otherwise benefit from co-generated energy;
litigation or legal proceedings, including product liability and environmental claims;
our ability to protect our intellectual property rights and know-how;
our ability to generate the funds required to service our debt and finance our operations;
fluctuations in foreign currency exchange and interest rates;
the availability and efficiency of hedging;
changes in international and local economic conditions, including with regard to the Euro, dislocations in credit and capital markets and inflation or deflation;
potential impairments or write-offs of certain assets;
required increases in our pension fund contributions;
the adequacy of our insurance coverage;
changes in our jurisdictional earnings mix or in the tax laws or accepted interpretations of tax laws in those jurisdictions;
our indemnities to and from Evonik (as defined below);
challenges to our decisions and assumptions in assessing and complying with our tax obligations; and
potential difficulty in obtaining or enforcing judgments or bringing actions against us in the United States.
In light of these risks, our results could differ materially from the forward-looking statements contained in this report and no undue reliance should be placed on those forward-looking statements. For further information regarding factors that could affect our business and financial results and the related forward-looking statements, see “Item 1A. Risk Factors.”
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Information about market risks for the period ended March 31, 2020 does not differ materially from that discussed under Item 7A of our 2019 Form 10-K.
Item 4. Controls and Procedures
As March 31, 2020, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended. Based upon that evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of that date.
There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended March 31, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

36



PART II
Item 1. Legal Proceedings

We become involved from time to time in various claims and lawsuits arising in the ordinary course of our business, such as employment related claims and asbestos litigation, against some of which we have limited indemnification from Evonik under the agreements relating to the Acquisition. Some matters involve claims for large amounts of damages as well as other relief. With respect to our settlement of the EPA’s enforcement initiative and the arbitration proceedings with Evonik see “Item 1. Business—Environmental, Health and Safety Matters—Environmental—Environmental Proceedings.” and “Item 1A. Risk Factors—Legal and Regulatory Matter—Litigation or legal proceedings could expose us to significant liabilities and thus adversely affect our business, financial condition, results of operations and cash flows.” as well as “Item 1A. Risk Factors—Legal and Regulatory Matter—We may not be able to protect our intellectual property rights successfully” included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, and is incorporated herein by reference. We believe, based on currently available information, that the results of the proceedings referenced above, in the aggregate, will not have a material adverse effect on our financial condition, but may be material to our operating results and cash flow for any particular period when the relevant costs are incurred. We note that the outcome of legal proceedings is inherently uncertain, and we offer no assurances as to the outcome of any of these matters or their effect on the Company.
Item 1A. Risk Factors
You should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, which could materially affect our business, financial position, or future results of operations. The risks described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations. The risk factors set forth below update, and should be read together with, the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

Risks Related to Our Business

The COVID-19 pandemic has had and could continue to have an adverse effect on our business and results of operations.

Our global operations expose us to risks associated with public health crises and outbreaks of epidemic, pandemic, or contagious diseases, such as the current outbreak of a novel strain of coronavirus (COVID-19). The COVID-19 pandemic has negatively impacted the global economy and created significant volatility and disruption of financial markets. Many state and local jurisdictions have imposed “shelter-in-place” orders, quarantines and restrictions on travel and mass gatherings to slow the spread of the virus and have required many “non-essential” businesses to close operations or shift to a remote working environment.

To date, the COVID-19 pandemic has adversely impacted our operations in a number of ways, including as a result of disruptions to our supply chain, disruptions and restrictions on the ability of many of our employees to work effectively because of illness, quarantines, government actions, facility closures and other restrictions, as well as temporary closures of certain of our facilities and those of certain of our customers and suppliers. If we continue to experience operational or supply chain disruptions, or such disruptions are exacerbated in the future, our business, results of operations and liquidity may be adversely impacted. In particular, the inability of our suppliers to meet our supply needs in a timely manner or our quality standards could cause delays in delivery to our customers, which could result in the cancellation of orders, customers’ refusal to accept deliveries, a reduction in purchase prices, and termination of customer relationships, any of which could have a material adverse effect on our business, financial condition, results of operations and liquidity. Even if we are able to find alternate sources for our supply needs, they may cost more, which could adversely impact our profitability and financial condition.

In addition, we have experienced significant and unpredictable reductions in the demand for our products as a result of the COVID-19 pandemic and further economic uncertainty may cause additional delays, cancellation, or redirections of planned orders. We experienced a significant decline in tire volume in the U.S. and Western Europe in the last two weeks of the quarter ended March 31, 2020, as the COVID-19 pandemic was declared a global pandemic.

The COVID-19 pandemic has adversely affected, and may continue to adversely affect, the economies and financial markets of many countries, as well as unemployment levels, which may result in a period of regional, national, and global economic slowdown or regional, national, or global recessions that could curtail or delay spending by our customers’ customers, in particular in the automotive industry, as well as increased risk of customer defaults or delays in payments. Our customers may terminate or amend their agreements for the purchase of our products due to decline in their demand and production, bankruptcy, lack of liquidity, lack of funding, operational failures, or other reasons. COVID-19 and the current financial, economic, and capital markets environment, and future developments in these and other areas present material uncertainty and risk with respect to our performance, financial condition, volume of business, results of operations, and cash flows.




The foregoing and other continued disruptions to our business as a result of COVID-19 could have an adverse effect on our business, financial condition and results of operations. The extent of the impact of COVID-19 on our operational and financial performance will depend on future developments, including the duration and spread of the COVID-19 outbreak, which is highly uncertain and cannot be predicted at this time.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None
38




Item 6. Exhibits

Exhibit Number Description
3.1
10.1 *
10.2 *
10.3 *
10.4 *
10.5 *
10.6
10.7
10.8 *
10.9 *
10.10 *
31.1 *
31.2 *
32.1 **
32.2 **
101.0 * XBRL
* Filed herewith
** Furnished herewith




SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ORION ENGINEERED CARBONS S.A.
May 7, 2020 By /s/ Lorin Crenshaw
Name: Lorin Crenshaw
Title: Chief Financial Officer

40

          IMAGE01.JPG
September 2, 2018

Mr. Corning Painter
4807 Leeds Court
Center Valley, PA 18034






Dear Corning:

I am pleased to offer you employment with Orion Engineered Carbons LLC and the appointment as Chief Executive Officer (CEO) of Orion Engineered Carbons S.A. group (collectively, “Orion” or “Company”). Your position will generally be located in Houston, TX.

The purpose of this letter is to describe the general terms and conditions of your employment with Orion.

POSITION AND DUTIES

You will serve as Chief Executive Officer and “Class A Daily Manager” of Orion Engineered Carbons S.A., Managing Director of Orion Engineered Carbons LLC and such other subsidiaries and affiliates of Orion as designated by the Board of Directors of Orion Engineered Carbons S.A. (the “Board”). In that capacity, you will report directly to the Board and have all of the customary authorities, duties and responsibilities that accompany these positions. You will devote substantially all of your working time, attention and energies during normal business hours (other than absences due to illness or vacation) to the performance of your duties for Orion and will not serve on the board of directors, trustees or any similar governing body of any other for-profit entity. Notwithstanding the foregoing, to the extent such activities do not interfere with the performance of your duties and responsibilities to Orion and are consistent with Orion’s Code of Conduct and other written compliance guidelines, (1) you will be permitted to serve, subject to prior consultation with the Board, on civic and charitable boards and committees and (2) you will be permitted to serve on the board of directors, trustees or any similar governing body of other public companies subject to the prior approval of the Board (which the Board anticipates providing, after a reasonable period of service with Orion, for up to two mutually agreeable public company boards).

1


          IMAGE01.JPG

COMPENSATION

Your annualized gross salary, before applicable deductions and withholding, will be $850,000 (“Salary”). In addition, you will be eligible to participate in Orion’s annual cash bonus plan with a target opportunity of 100% of Salary and a maximum opportunity of 200% of Salary. Payouts under the annual bonus plan will be tied to the achievement of the Company and your established written personal performance goals. Your 2018 bonus will be prorated based on your actual start date.

Beginning with Orion’s 2019 fiscal year, you will be eligible to participate in Orion’s annual long term incentive (LTI) program and receive annual equity-based awards with an aggregate grant date value (at the target level) equal to 300% of Salary at such time as awards are generally granted to other employees, subject to such vesting conditions, restrictions and performance goals as may be determined in the sole discretion of the Compensation Committee of the Board. The type and mix of LTI instruments used are subject to change.

Within 60 days of your start date, subject to Board approval, you will receive a one-time time-vested restricted stock unit grant with a grant date value of $1,000,000. One-third of this time-vested restricted stock unit grant will vest on the one, two and three year anniversaries of your start date, respectively. If your employment is terminated by Orion for any reason other than Cause or by you for Good Reason or due to death or Disability (as defined below), this time-vested award will fully vest upon the termination of your employment. This award will be subject to the terms and conditions of the relevant equity plan and the award agreement governing the grant. “Cause” means: (1) your conviction, whether following trial or by plea of guilty or nolo contendere (or similar plea) in a criminal proceeding (a) on a misdemeanor charge involving fraud, false statements or misleading omissions, wrongful taking, embezzlement, bribery, forgery, counterfeiting or extortion, or any other crime involving moral turpitude, (b) on a felony charge or (c) on an equivalent charge to those in clauses (a) and (b) in jurisdictions which do not use those designations; (2) continued material failure to perform your duties after notice from Orion; (3) engagement in illegal conduct or gross misconduct, in either case, that causes material financial or reputational harm to Orion; (4) material violation of Orion’s codes of conduct or any other Orion policy as in effect from time to time; or (5) breach of any of the material terms of any agreement between you and Orion, in the case of (2), (4) and (5), subject to your failure to remedy to the reasonable satisfaction of the Company within 30 days after written notice is delivered by the Company to you setting forth in reasonable detail the basis of “Cause,” if such act is curable, as determined in good faith by Orion. An event will not constitute Cause unless the Company gives you notice of termination within 90 days after the Board becomes aware that an event constituting Cause has occurred describing in reasonable detail the event constituting Cause.

You will receive a one-time cash bonus of $ 410,000 to offset the loss of your estimated current year prorated bonus and other expenses. The bonus will be reduced by applicable deductions and withholding and will be paid on your first regularly scheduled paycheck from Orion. In the event that you voluntarily resign employment with Orion within twelve (12) months of your start date, you will reimburse Orion the net amount of the signing bonus, reduced by 1/12 for each full month of employment with Orion prior to the resignation date. This payment will be made to Orion no later than thirty (30) days after said termination.

2


          IMAGE01.JPG

BENEFITS

In addition to your salary, you will be eligible for benefits commensurate with the benefits offered to all other Orion employees (as applicable) in a similar status, subject to any applicable restrictions, waiting periods and other terms and conditions. You will start with five weeks of vacation per year.

RELOCATION

You are eligible for a Guaranteed Buy Out (GBO) relocation package. Information about your relocation package will be provided in due course. Additionally, during the initial year of your employment, we will reimburse reasonable business commuting expenses between your home in Center Valley and Orion’s offices in Luxembourg, Frankfurt and Houston.

SEVERANCE; CHANGE OF CONTROL

If Orion terminates your employment other than for Cause or you terminate your employment with Orion or its successor or assign for Good Reason (as defined below), then you will be entitled to receive (1) cash severance in an amount equal to one (1) times the sum of your then-current Salary plus your target annual cash bonus for such period in which the termination occurs (“Severance Amount”) and (2) upon your timely election, for one (1) year following the date of termination, continued health care coverage with premiums to be paid at active employee rates, to run concurrently with coverage required under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), provided, that the Company may provide payments in lieu of benefits thereof, (such payments and benefits described in this paragraph, “Non-Change in Control Severance”). “Good Reason” means that, with respect to your employment at Orion or its successors and without your consent, (1) your position, duties, or authority are materially diminished (2) your annual base salary is reduced or another material element of your compensation is reduced or eliminated or (3) your primary work location is relocated to an office that is more than a hundred miles from Houston or (4) breach of any of the material terms of this letter or any other agreement between you and Orion. Notwithstanding the foregoing, an event will not constitute Good Reason unless (a) you give a notice of termination within 90 days after you become aware that an event constituting Good Reason has occurred describing in reasonable detail the event constituting Good Reason, (b) Orion is given 30 days after it receives such notice to cure such event and (c) your termination occurs no later than 30 days after Orion’s failure to cure such event.

If your employment with Orion terminates due to your death or Disability (as defined below), then you (or your estate upon your death) will be entitled to receive an amount equal to the Severance Amount multiplied by a fraction, (1) the numerator of which is (x) 12 minus (y) the number of full or partial months elapsed in the fiscal year in which the termination occurs to the date of termination and (2) the denominator of which is 12 (the “Death/Disability Amount”). “Disability” means your incapacity due to physical or mental illness that results in your having been substantially unable to perform your duties to the Company for a continuous period of 180 days.

If a “Change in Control Termination Event” occurs, you will be entitled to receive, in lieu of Non-Change in Control Severance, (1) cash severance in an amount equal to three (3) times the Severance Amount and (2) upon your timely election, for three years following the date of termination, continued health
3


          IMAGE01.JPG


care coverage with premiums to be paid at active employee rates, to run concurrently with coverage required under COBRA, provided that the Company may provide payments in lieu of benefits thereof. A “Change in Control Termination Event” means that you are terminated by Orion for other than for Cause or you terminate your employment with Orion or their successors for Good Reason (as defined above) within 1 year following a Change in Control (as defined below), provided that you are employed by Orion on the date of the Change in Control. A “Change in Control” has the meaning set forth in Orion’s 2014 Omnibus Incentive Compensation Plan (or any successor thereto, to the extent that such successor plan definition is more favorable to you).

Such Change in Control severance payments and Non-Change in Control Severance or Death/Disability Amount payments will be made to you in equal monthly installments over one (1) year, except in case of death, in which case payments shall be made in a lump sum, each in accordance with Orion’s customary payroll practice and (other than in the event of your death) will be payable only if, within 60 days following the date your employment is terminated, you enter into (and do not revoke) a release of claims in favor of Orion in a form and substance satisfactory to Orion acting in good faith. Absent your consent, which may be withheld, such release shall not contain any additional restrictive covenants other than those which appear in your Restrictive Covenants Agreement dated ●, 2018. Payments will begin on the first payroll date following the effective date of the release of claims, unless otherwise required by law or a delay in payment is required as explained below under “Compliance with Section 409A.”
In addition, in the event of a Change in Control Termination Event, all equity-based awards granted to you within the initial twelve (12) months after your start date will vest (at target for performance-based awards) upon such event. Upon any other termination of employment, your equity-based awards will be treated as provided under the applicable plan and award agreement.

RESTRICTIVE COVENANTS

This offer and your employment with Orion are contingent with your entering into the enclosed Restrictive Covenants Agreement.

4


          IMAGE01.JPG

COMPLIANCE WITH SECTION 409A

It is intended that the provisions of this letter agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), and all arrangements set forth herein shall be construed, interpreted and implemented in a manner consistent with the requirements of Section 409A. The Parties hereto agree to interpret, apply, and administer this Agreement in the manner necessary to comply therewith.

For purposes of any payments to be made upon your termination of employment, such term will mean your “separation from service” as defined under section 409A. For purposes of Section 409A, each payment of deferred compensation or in-kind benefits under this agreement will be deemed to be a separate payment. In the event that any payments under this letter agreement constitute “deferred compensation” subject to Section 409A and you are a “specified employee” as defined under Section 409A, any payments on account of any such “separation from service” for which delay of payment is required under Treasury Reg. Section 1.409A-3(i)(2) shall be paid on the first day of the seventh month following your termination of employment, or if earlier, the date of your death. The Company will consult with you in good faith regarding the implementation of the provisions of this section.

If the time period in which you may execute or revoke the release of claims or execute the non-competition and non-solicitation agreement described above under “Severance; Change of Control” spans two calendar years, no payments subject to Section 409A will be made until the second such calendar year.

INDEMNIFICATION AND DIRECTORS’ AND OFFICERS’ LIABILITY INSURANCE

Reference is made to Article 22 (Indemnification) of the Orion Engineered Carbons S.A. articles of association which is applicable to you as an officer and – potentially – director of Orion. You will be entitled to coverage under Orion’s directors’ and officers’ liability insurance policy on substantially the same terms as for Orion’s other officers.

ENTIRE AGREEMENT/EMPLOYMENT AT WILL

This offer letters contains the entire understanding between you and the Company and supersedes any prior representations, in any form, that may have been made regarding your prospective employment at the Company and may not be changed or modified in any way except in writing from an authorized representative of the Company. Nothing contained in this offer letter is intended or should be construed as a contract for any term of employment, either express or implied, with Orion. Should you accept this offer of employment, you understand that your employment will be on an at-will basis and is not for any fixed period of time. This means that either you or the Company can terminate the employment relationship at any time, with or without cause. If your employment as Chief Executive Officer of Orion terminates at any time, you shall resign from any position you hold at such time with Orion or its affiliates, including as an officer and/or director and “Class A Daily Manager”.



5


          IMAGE01.JPG

EMPLOYMENT ELIGIBILITY

This offer of employment is contingent upon satisfactory completion of the Company’s standard onboarding procedures no later than three (3) business days after your start date. In addition, this offer is contingent upon satisfactory completion of a background investigation as well as successfully passing a drug screen. By signing this offer letter, you hereby release the Company, its subsidiaries and affiliates, and their respective officers, directors, employees, and agents, and any entitles or individuals who may provide the Company with information regarding your background, from any liability of any kind or nature in connection with requesting or providing such information to third parties in connection with the background investigation and drug screening.

CURRENT AND PRIOR EMPLOYERS

Orion is hiring you because of your skills, abilities and qualifications for the work to be performed. We are not hiring you in order to obtain trade secrets, confidential or proprietary information from any of your current or prior employers (collectively, “Confidential Information”). Accordingly, as we have indicated to you, you shall not bring with you to your employment, or use in any other manner, any Confidential Information from such current or prior employers. Therefore, please make certain that you return any such Confidential Information to your current or prior employers, if you have not done so already, before you commence your employment with Orion. Further, you agree that in the course of your employment with the Company, you will not disclose to the Company or use on behalf of the Company any legally protected Confidential Information or documents of any current or former employer.

You have advised us and acknowledge that you are not a party to any type of confidentiality, non-compete, non-solicitation or other agreement between you and any current or former employer, or the subject of any court order, that restricts or might restrict your employment or performance of duties with the Company.

MISCELLANEOUS

This letter agreement will be governed by the laws of the state of Texas without regard to its conflicts of law principles. To the extent permitted by law, you and Orion waive any and all rights to a jury trial with respect to any dispute arising out of or related to your employment with Orion. This letter agreement may be executed in any number of counterparts, each of which will be deemed original and to constitute one and the same instrument.

6


          IMAGE01.JPG

CONDITIONS OF EMPLOYMENT

This offer remains open until September 3rd, 2018 and is subject to satisfaction of the employment eligibility conditions described above. If the terms of this offer are acceptable, please indicate your agreement by signing, dating and returning this offer letter to me so that is it received by September 3rd. You will then be contacted regarding the background check and drug screening should you accept the position. Your anticipated start date is September 4th, 2018.

Corning, I genuinely hope you will accept this offer to join us. I believe you will make an outstanding CEO of Orion and contribute greatly to its future success. We are looking forward to the prospect of your being a part of our team and that of Orion.

Sincerely,

Orion Engineered Carbons S.A.

By: _______________________________
Dan Smith
Member, Board of Directors of Orion





ACCEPTED:


_______________________________  ___________________________
SIGNATURE      DATE SIGNED

7

Execution Version

September 2, 2018

Mr. Corning Painter
4807 Leeds Court
Center Valley, PA 18034

Re: Restrictive Covenants Agreement

Dear Corning:

        Orion Engineered Carbons S.A. (together with its subsidiaries and affiliates, “Orion” or “the Company”) is entering into a letter agreement with you, dated September 1, 2018 (your “Letter Agreement”), which establishes your compensation and certain terms of your employment as Chief Executive Officer of Orion Engineered Carbons, S.A. In consideration of your appointment as Chief Executive Officer and the payments to be made to you under the Letter Agreement (including, without limitation, potential termination benefits), you agree as follows:

1.Covenants.
(a)Protected Information. You recognize and acknowledge that you will have access to various confidential or proprietary information concerning Orion of a special and unique value, including without limitation: (1) books and records related to operation, finance, accounting, sales, personnel and management; (2) policies and matters related particularly to operations such as customer service requirements, costs of providing service and equipment, operating costs and pricing matters; and (3) various trade or business secrets, including business opportunities, marketing or business diversification plans, business development and bidding techniques, methods and processes, financial data and the like (collectively, the “Protected Information”). You shall not at any time during the Restricted Period, or at any time thereafter, make use of or disclose, directly or indirectly, to any other person or organization (except as authorized by Orion) any Protected Information. This section shall not apply: (A) to the extent you are required to disclose Protected Information by law, court order, or governmental authority, provided that you shall promptly notify Orion, to the extent permitted, of any such required disclosure and will use your reasonable best efforts to ensure that Orion has sufficient time to intervene or object to such disclosure or otherwise act to protect its interests and you shall not disclose any Protected Information while any such objection is pending to the extent permitted and Orion shall indemnify you for any reasonable legal fees or other costs incurred by you in relation to providing such notice or in connection with any such pending objection by Orion; or (B) to any information that is available to the general public through no act or omission of you.
(b)Non-Competition; Non-Solicitation. You acknowledge that (1) in your role as Chief Executive Officer, you will receive Protected Information, including Company trade secrets and (2) that the Company has devoted extensive time, effort and resources in maintaining a stable workforce and that, as a result of your role as Chief Executive Officer, you will have direct contact and dealings with employees of the Company, and therefore, (A) you acknowledge and agree that the Company’s goodwill is inextricably

SC1:4699850.5


intertwined with such relationships and information and that the following restrictions are both reasonable and commensurate with and in light of the foregoing and (B) you further acknowledge that the goodwill and other proprietary interests of the Company will suffer irreparable and continuing damage in the event you enter into competition with the Company.
(i)During the Restricted Period, you agree that you will not, directly or indirectly, engage in, assist or have any active interest or involvement, whether as an employee, agent, consultant, creditor, advisor, officer, director, stockholder (excluding a stockholder of less than 1% of the stock of a public company), partner, proprietor or any type of principal whatsoever, in any person, firm or business entity that directly or indirectly is engaged in any business which is in competition with any business that Orion is then engaged in or is in development by Orion at such time (or, following your termination of employment, any business that Orion was engaged in or was in development by Orion as of the date of your termination of employment).
(ii) During the Restricted Period, you shall not in any manner, directly or indirectly, recruit, solicit for employment, hire or cause to be hired by any non-Orion entity any individual who is then, or who has been within the preceding six-month prior to the termination of your employment with Orion, an employee of Orion or any of Orion’s clients.
(c)Non-Disparagement. During your employment with Orion and for five years after the date your employment terminates, you shall not, directly or indirectly, in public or private, deprecate, impugn, disparage or make any remarks that would tend to be construed or be construed to defame you or any of Orion or its officers or members of the board of directors, nor shall you assist any other person, firm or company in so doing, other than intra-Company discussions that are in furtherance of the ordinary course performance of your duties with the Company. For the avoidance of doubt, nothing in this Agreement precludes you from (1) making any truthful statements in testimony required pursuant to a court order, subpoena, or other valid legal process or (2) making any truthful statements in connection with a court order, subpoena or other valid legal process in the course of enforcing the terms of your employment agreement dated September 2, 2018 or any other agreement between you and the Company.
(d)Return of Documents and Other Materials. Upon your date of termination for any reason, or at any other time as Orion may request, you shall promptly return to Orion all records, memoranda, notes, plans, reports, computer tapes and equipment, software and other documents or data which constitute Protected Information which you may then possess or have under your control (together with all copies thereof whether in paper, electronic or other form) and all credit cards, keys and other materials and equipment which are Orion’s property that you have in your possession or control.
(e)Notwithstanding anything to the contrary in this letter or otherwise, nothing shall limit your rights under applicable law to provide truthful information to any governmental entity or to file a charge with or participate in an investigation conducted by any governmental entity. You are hereby notified that the immunity provisions in
-2-
SC1:4699850.5


Section 1833 of title 18 of the United States Code provide that an individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (1) in confidence to federal, state or local government officials, either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law, (2) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (3) to your attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and the trade secret is not disclosed except pursuant to court order.
2.Definitions.
Restricted Period” means the period commencing on the start date of your employment with Orion and ending on the one-year anniversary of the termination of your employment for any reason; provided that in the event of a Change in Control Termination Event (as defined in your Letter Agreement), the Restricted Period shall end on the three-year anniversary of the termination of your employment.
3.Additional Terms.
(a)Enforcement of Covenants.
(i) You agree that given the nature of Orion’s business, and as further set forth in Section 1, the scope and duration of the covenants set forth in Section 1 above are reasonable and necessary to protect the legitimate business interests of Orion and do not unduly interfere with your career or economic pursuits. You recognize and agree that in the event that you breach any of the covenants set forth in Section 1 (a), (b) and (c), or a material breach of Section (d), each during the Restricted Period, Orion shall have the right to discontinue any or all remaining payments or benefits payable pursuant to your Letter Agreement. Such termination of employment or discontinuance of benefits shall be in addition to and shall not limit any and all other rights and remedies that Orion may have against you.
(ii) You acknowledge that a breach of any of the covenants set forth in Section 1 (a), (b) and (c), or a material breach of Section (d) above will each constitute immediate and irreparable harm to Orion’s business, for which damages cannot be readily calculated and for which payment of damages is an inadequate remedy. Accordingly, you acknowledge that Orion shall be entitled to seek an injunction or injunctions to prevent any breach or threatened breach of any covenant set forth in Section 1 (a), (b) and (c), or a material breach of Section (d) above, and you hereby consent to the issuance thereof, forthwith and without bond by any court of competent jurisdiction.
(b)Governing Law. This letter will be governed by the laws of the state of  Texas without regard to its conflicts of law principles.
-3-
SC1:4699850.5


(c)Severability and Reformation. Whenever possible, each provision of this letter shall be interpreted in such manner as to be effective, valid and if appropriate, reformed under applicable law, but if any provision of this letter is held to be invalid, illegal or unenforceable under applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of such provision in any other jurisdiction, but this letter shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. If a court holds that the restrictions stated herein are unreasonable, the parties hereto agree that the maximum period, scope or geographical area reasonable under the circumstances shall be substituted for the stated period, scope or area and that the court shall be allowed to revise the restrictions contained herein to cover the maximum period, scope and area permitted by law.
(d)Survival. The provisions of this letter will survive any termination of your employment with Orion for the applicable time periods set forth herein.
*  *  *

-4-
SC1:4699850.5


Sincerely,
Orion Engineered Carbons S.A.
By:  ____________________________
        Dan Smith
        Member, Board of Directors of Orion
        
        



I agree with and accept the foregoing terms.




____________________________
Corning Painter
Signature Page to Restrictive Covenants Agreement

SC1:4699850.5

ORION ENGINEERED CARBONS LLC
2018 Restricted Stock Unit Award
Notice of Grant


PARTICIPANT NAME:     Corning Painter
PARTICIPANT ID:      CEO
GRANT DATE:      November 2, 2018
NUMBER OF RESTRICTED STOCK UNITS:1    35,817

We are pleased to inform you that, pursuant to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, you have been made an award of restricted stock units, subject to the terms and conditions set forth in the attached Award Agreement.
* * *
ORION ENGINEERED CARBONS LLC
Restricted Stock Unit
Award Agreement

This Restricted Stock Unit Award Agreement (this “Agreement”) is entered into by and between Orion Engineered Carbons LLC (the “Company”) and you (the “Participant”) pursuant and subject to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, as may be amended from time to time (the “Omnibus Plan”). All capitalized terms not defined in this Agreement shall have the meaning stated in the Omnibus Plan. If there is any inconsistency or conflict between the terms of this Agreement and the terms of the Omnibus Plan, the terms of the Omnibus Plan shall control and govern unless this Agreement expressly states that an exception to the Omnibus Plan is being made.
1.Grant of Restricted Stock Units. On the terms and conditions set forth below, the Company hereby grants to the Participant the number of restricted stock units set forth in the Notice of Grant (such number of restricted stock units, the “Restricted Stock Units”).
2.Vesting; Settlement.
(a)The Restricted Stock Units are subject to forfeiture until they vest. One-third of the Restricted Stock Units will vest and become non-forfeitable on
        -1-
SC1:4723898.2


each of the first, second and third anniversary of the date you commenced employment with the Company (the “Start Date”) (each anniversary, a “Scheduled Vesting Date”), subject to the Participant’s service as an employee of the Company through the applicable Scheduled Vesting Date.
(b)Any unvested Restricted Stock Units shall vest and become non-forfeitable upon the termination of employment of the Participant by the Company without Cause, by the Participant for Good Reason or due to death or Disability (each an “Acceleration Event”) (the earliest to occur of the Scheduled Vesting Date or the date an Acceleration Event occurs, the “Vesting Date”), subject to execution and subsequent effectiveness of a Release, as defined below.
(c)Upon vesting, a number of Shares in Orion Engineered Carbons S.A. equal to the number of Restricted Stock Units that vest (or, at the Company’s election, an amount of cash equal to the Fair Market Value of such number of Shares) shall be delivered to Participant as soon as administratively feasible after the Vesting Date and in no event later than 45 days following the Vesting Date (the date the Shares are so delivered, the “Delivery Date”).


SC1:4723898.2


3.Forfeiture; Release.
(a)General. Except as otherwise provided in Section 2(b), if the Participant’s employment with the Company is terminated for any reason prior to the Scheduled Vesting Date, all Restricted Stock Units shall immediately be forfeited.
(b)Release. In the case of the Participant’s termination by the Company without Cause or by the Participant for Good Reason, the Participant shall, as a condition to receiving delivery of any Shares (or cash) under this Agreement, execute an agreement providing for a general release of claims in favor of the Company in the form required by certain terms of the Participant’s employment agreement terms reflected in the Offer Letter of Orion Engineered Carbons S.A. dated September 2, 2018 (the “Release”) and the Release must be executed by the Participant and become irrevocable prior to the date the delivery of Shares with respect to the Restricted Stock Units is scheduled to be made pursuant to Section 2(c); provided that if the Release is executed after such time, the Restricted Stock Units and any right to receive Shares or cash in respect thereof shall be forfeited.
4.Definitions.
(a)Cause” has the definition set forth in the Participant’s offer letter with Orion Engineered Carbons S.A., dated September 2, 2018.
(b)Disability” means a Participant’s incapacity due to physical or mental illness resulting in the Participant having been substantially unable to perform his or her duties hereunder for a continuous period of 180 days.
(c)Good Reason” has the meaning set forth in the Participant’s offer letter with Orion Engineered Carbons S.A., dated September 2, 2018.
5. Dividends. The Participant shall not be entitled to receipt of any dividends or other distributions paid on Shares prior to the Delivery Date.
6.Adjustments. If any change is made to the outstanding Shares or the capital structure of the Company, the Restricted Stock Units will be adjusted as contemplated by Section 1.6.3 of the Omnibus Plan.
7.Withholding for Taxes. The delivery of Shares under this Plan is conditioned on the Participant’s satisfaction of any applicable taxes in accordance with Section 3.2 of the Omnibus Plan.
8.Clawback/Recapture Policy. The Restricted Stock Units shall be forfeited, and following the delivery of Shares (or cash), the Company shall be entitled to receive, and the Participant shall be obligated to repay the Company immediately upon demand therefor, the Fair Market Value of the Shares (determined as of the

SC1:4723898.2


Scheduled Vesting Date) and the amount of cash (to the extent that any cash was delivered in lieu of Shares) delivered, net of any taxes withheld on the original payment to the Participant if, as determined by the Committee in its discretion:
(a)A material downward restatement of the Company’s financial statements with respect to any period between the Start Date and the final Vesting Date;
(b)The Participant violates any confidentiality, non-competition or non-solicitation obligation to the Company, including but not limited to those set forth in any employment agreement or offer letter between the Participant and the Company and/or Orion Engineered Carbons S.A.; or
(c)The Participant’s employment is terminated due to Cause that existed during the period between the Start Date and the final Vesting Date.
9.Rights as Stockholder. The Participant shall have no rights as a stockholder with respect to the Shares underlying the Restricted Stock Units granted under this Agreement unless and until the Restricted Stock Units vest and are settled by the issuance of such Shares.
10.Employment. Neither the granting of the Restricted Stock Units nor any term or provision of the Notice of Grant or this Agreement shall confer, constitute or be evidence of any understanding, express or implied, on the part of the Company or any of its subsidiaries to guarantee the Participant’s continued employment with the Company.
11.Disposition or Pledge of Restricted Stock Units.
(a)The Participant may not dispose (including pledge and otherwise encumber) of any unvested Restricted Stock Units, unless the Participant requests to do so in writing and the Committee consents to same in writing. The same applies to any transactions which, from an economic perspective, are similar to a disposition of unvested Restricted Stock Units.
(b)The Committee's consent to a disposal by a Participant to a legal entity controlled and solely represented by such Participant or to a member of his/her family shall not unreasonably be withheld.
12.Compliance with Securities Laws. The Company will not be required to deliver any certificates in respect of Restricted Stock Units pursuant to this Agreement, if, in the discretion of the Committee (or its delegate), such issuance would violate any applicable securities laws or stock exchange and other regulatory requirements. Prior to the vesting of or issuance of any certificates in respect of Restricted Stock Units pursuant to this Agreement, the Company may require that the Participant (or the Participant’s legal representative upon the Participants’ death or Disability, as applicable) enter into such written representations, warranties and agreements as the

SC1:4723898.2


Company may reasonably request in order to comply with applicable laws or with this Agreement.
13.Amendment. This Agreement may be amended by the Committee at any time, provided that, except as otherwise provided in the Director Plan, no such amendment, without the written consent of the Participant, shall materially adversely impair the rights of the Participant granted hereunder.
14.Miscellaneous.
(a)Compliance with Section 409A. The Restricted Stock Units are intended to be exempt from Section 409A, and this Agreement shall be interpreted, administered and construed to give effect to such intent. If any payment or delivery to be made under this Agreement would be subject to the limitations in Section 409A(a)(2)(B) of the Code, the payment or delivery will be delayed until six months after the Participant’s separation from service (or earlier death) in accordance with the requirements of Section 409A. Each payment or delivery under this Agreement will be treated as a separate payment or delivery for purposes of Section 409A.
(b)Headings. The headings in this Agreement are inserted for convenience only and shall have no significance in the interpretation of this Agreement.
(c)Entire Agreement. This Agreement, the Notice of Grant and the Omnibus Plan contain the entire agreement between the parties with respect to the transactions contemplated hereunder and supersede any prior arrangements or understandings with respect thereto, written or oral. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement, including the Omnibus Plan and any and all attachments hereto.
(d)Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom the Restricted Stock Units may be transferred by will or the laws of descent and distribution.
(e)Repatriation. If the Participant is resident outside of the United States, the Participant agrees as a condition of the grant of the Restricted Stock Units to repatriate all payments attributable to the Restricted Stock Units acquired under the Omnibus Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Restricted Stock Units once vested) if required by and in accordance with local foreign exchange rules and regulations in the Participant’s country of residence. In addition, the Participant also agrees to take any and all actions, and consent to any and

SC1:4723898.2


all actions taken by the Company and its subsidiaries, as may be required to allow the Company and its subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence. Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant’s country of residence.
(f)Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without reference to principles of conflict of laws.
(g)CONSENT TO JURISDICTION. BY ACCEPTING THIS AWARD, THE PARTICIPANT EXPRESSLY AND IRREVOCABLY AGREES TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL OR STATE COURT LOCATED IN NEW YORK, NEW YORK, U.S.A. IN RESPECT OF ANY MATTER HEREUNDER. This includes any action or proceeding to compel arbitration or to enforce an arbitration award.
(h)No Right to Future Grants.  The grant of the Restricted Stock Units is voluntary and does not create any contractual or other right to receive future grants of Restricted Stock Units, or benefits in lieu of Restricted Stock Units, even if Restricted Stock Units have been granted repeatedly in the past.  All decisions with respect to future grants, if any, will be at the sole discretion of the Committee. Notwithstanding any other agreement with the Participant, the Restricted Stock Units are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. The future value of the underlying Shares is unknown and cannot be predicted with certainty. No claim or entitlement to compensation or damages arises from forfeiture or termination of the Restricted Stock Units or diminution in value of the Restricted Stock Units or the underlying Shares and the Participant irrevocably releases the Committee, the Company and/or its subsidiaries (and their respective directors and officers) from any such claim that may arise.  The Omnibus Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, suspended or terminated by the Company at any time, as provided in the Omnibus Plan.  The Participant’s participation in the Omnibus Plan is voluntary. Any amendment, modification, or termination of the Omnibus Plan shall not constitute a change or impairment of the terms and conditions of the Participant’s employment with the Company and/or its subsidiaries.
15.Severability. The invalidity or unenforceability of any provision of the Omnibus Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Omnibus Plan or this Agreement.

SC1:4723898.2


16.Electronic Delivery.  The Company may, in its sole discretion, deliver any documents related to the Restricted Stock Units by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Omnibus Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
17.Employee Data Privacy.  The Participant hereby explicitly consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this document by and among, as applicable, the Company and its subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Omnibus Plan. The Participant understands that the Company holds certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Restricted Stock Units or any other entitlement, for the purpose of implementing, administering, and managing the Omnibus Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting the Company in the implementation, administration, and management of the Omnibus Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local Human Resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Omnibus Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Restricted Stock Units or Shares acquired. The Participant understands that Data will be held only as long as is necessary to implement, administer, and manage the Participant’s participation in the Omnibus Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local Human Resources representative. The Participant understands, however, that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Omnibus Plan (and may result in the forfeiture of unvested Restricted Stock Units). For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Company’s General Counsel or head of Human Resources.  
18.Acceptance. The Participant hereby acknowledges receipt of a copy of the Omnibus Plan and this Agreement. The Participant has read and understands the terms and provisions thereof, and accepts the Restricted Stock Units subject to all of the terms and conditions of the Omnibus Plan and this Agreement. The Participant acknowledges that there may be tax consequences upon the vesting or disposition of

SC1:4723898.2


the Restricted Stock Units and that the Participant has been advised to consult a tax advisor prior to such vesting, settlement or disposition.
IN WITNESS WHEREOF, this Agreement has been executed by the Company and accepted by the Participant, effective as of the date first above written.

ORION ENGINEERED CARBONS LLC 




Name: Jeffrey C. Malenky
Title: Senior Vice President, Global Human Resources




1 Note: Number of restricted stock units equals one-million USD ($1,000,000) divided by the closing price of the Company’s common stock on the NYSE on November 2, 2018 ($ 27.92

SC1:4723898.2
IMAGE011.JPG

Pat Tuttle
SVP, Global Human Resources

Orion Engineered Carbons LLC
4501 Magnolia Cove Drive
Suite 106
Kingwood, TX 77345
Email: pat.tuttle@orioncarbons.com
Phone: +1 832-445-3303
Fax +1 832 445-3333
Mobile +1 832 418-1572


               *** Supersedes October 4, 2019 Offer Letter ***

October 23, 2019

Lorin James Crenshaw
4600 Binfords Ridge Road
Charlotte, NC 28226
Email: lorincrenshaw@yahoo.com
          
Dear Lorin,

I am pleased to confirm the offer to you for the position of Chief Financial Officer for Orion Engineered Carbons S.A., reporting to Corning Painter, Chief Executive Officer. Commencement of your employment with the US legal entity Orion Engineered Carbons LLC will be scheduled on November 4, 2019.

Your starting salary will be $15,384.62 payable bi-weekly ($400,000.00 on an annual basis). Our current 401(k) plan provides company matching contributions of dollar-for-dollar on the first 2% of employee’s contribution, and fifty cents per dollar on the next 4% [total 4% company on employee 6%]; other benefits programs and Company policies will be discussed in detail at your orientation.

Due to your length of work experience, beginning in 2019 you will be eligible for 20 days of vacation per year, and will remain at that level until Company policy grants a higher level of entitlement based on years of service. Your vacation entitlement in 2019 will be prorated based on your start date. Our current year holiday schedule is enclosed.

You will be eligible to participate in the Company’s Bonus Plan at a target level of 65%, with a prorated entitlement in 2019. The bonus is normally paid by April of the following year and is payable only if you are actively employed on the date of payout. In addition, you will participate in our Long-Term Incentive Plan at 100% of base salary also with a prorated entitlement in 2019.

You will be provided a sign on Restricted Stock Unit (RSU) grant with a grant value of $200,000 after you start with Orion. These RSUs will vest by one-third each October 31st from 2020 to 2022. In addition, you will receive a sign on bonus in amount of $180,000, subject to your signing a repayment agreement for this bonus should you voluntarily resign within 12 months of your hire date. The first $100,000 of the sign-on bonus will be paid no later than 30 days after your start with Orion and the remaining $80,000 will be paid in March, 2020.



IMAGE011.JPG

You are eligible for relocation benefits under the Company Relocation Policy; the policy is enclosed. Our relocation management company is Relocation Synergy. They will contact you directly. Note that relocation benefits are subject to you signing our Relocation Repayment Agreement Form. In addition to the benefits outlined in the policy, we will provide up to 90 days of temporary housing assistance.

You will need to complete the following: a) your signing the enclosed Confidentiality and Proprietary Rights Agreement, and the Non-Compete, Non-Solicitation and Conflict of Interest Agreement; b) verification of your academic credentials; and c) a satisfactory reference/background check. You must satisfactorily complete a “pre-employment” physical examination that includes a Drug Screening. The physical must be taken no earlier than 30 days before you begin employment. Please contact Jacquelyn McWhorter at 832-405-8097 to coordinate scheduling of an appointment. The clinic will invoice us directly. You must fast for 12 hours prior to the exam, refrain from smoking, and drink water only.

You will also need to provide us with evidence of your eligibility to be legally employed in the United States as required by Federal Law. Please review the enclosed ‘List of Acceptable Documents’ and bring the original document(s) with you on your first day of work.

The regulations and policies of the Orion Engineered Carbons LLC will govern your employment. The Company may unilaterally amend these regulations and policies from time to time.

There are no agreements or understandings with respect to the employment except as expressly referenced herein and in the Employment Application. This agreement supersedes all prior discussions and negotiations with respect to the employment. This job offer is limited to the terms and conditions contained herein, and it may be amended only in writing signed by an authorized representative of the Company.

Employment at Orion Engineered Carbons LLC is At-Will. The Company reserves the right to change any of these policies, services or benefits at any time with or without notice. As an At-Will employee, either the Company or the At-Will employee can terminate the employment relationship at any time, for any or no reason, with or without notice.

Should you these revised terms, please indicate your agreement with the conditions described herein by signing this letter and returning it to me by October 28, 2019 along with a copy of the OEC Signing Bonus Repayment Agreement.

We are looking forward to your joining us and hope your career aspirations will be met within Orion Engineered Carbons. Feel free to call me if you have any questions.

Congratulations,

Patrick F. Tuttle
SVP, Global Human Resources
           
Read and Agreed:_____________________________ Date:___________________
Lorin James Crenshaw

Enclosures: Kingwood Holiday Schedule; Orion Benefits Handout; Confidentiality and Proprietary Rights Agreement; Noncompetition, Nonsolicitation, Nondisparagement Agreement; Conflict of Interest Agreement.
             


ORION ENGINEERED CARBONS LLC
2019 Restricted Stock Unit Award
Notice of Grant


PARTICIPANT NAME:     Lorin James Crenshaw
PARTICIPANT ID:      CFO
GRANT DATE:      November 4, 2019
NUMBER OF RESTRICTED STOCK UNITS:   10,689

We are pleased to inform you that, pursuant to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, you have been made an award of restricted stock units, subject to the terms and conditions set forth in the attached Award Agreement.
* * *
ORION ENGINEERED CARBONS LLC
Restricted Stock Unit
Award Agreement

This Restricted Stock Unit Award Agreement (this “Agreement”) is entered into by and between Orion Engineered Carbons LLC (the “Company”) and Lorin James Crenshaw (the “Participant”) pursuant and subject to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, as may be amended from time to time (the “Omnibus Plan”). All capitalized terms not defined in this Agreement shall have the meaning stated in the Omnibus Plan. If there is any inconsistency or conflict between the terms of this Agreement and the terms of the Omnibus Plan, the terms of the Omnibus Plan shall control and govern unless this Agreement expressly states that an exception to the Omnibus Plan is being made.
1.Grant of Restricted Stock Units. On the terms and conditions set forth below, the Company hereby grants to the Participant the number of restricted stock units set forth in the Notice of Grant (such number of restricted stock units, the “Restricted Stock Units”).
2.Vesting; Settlement.
(a)The Restricted Stock Units are subject to forfeiture until they vest. One-third of the Restricted Stock Units will vest and become non-forfeitable on
        -1-


each of October 31, 2020, October 31, 2021 and October 31, 2022, (each anniversary, a “Scheduled Vesting Date”), subject to the Participant’s service as an employee of the Company through the applicable Scheduled Vesting Date.
(b)Any unvested Restricted Stock Units shall vest and become non-forfeitable upon the termination of employment of the Participant by the Company without Cause, by the Participant for Good Reason or due to death or Disability (each an “Acceleration Event”) (the earliest to occur of the Scheduled Vesting Date or the date an Acceleration Event occurs, the “Vesting Date”), subject to execution and subsequent effectiveness of a Release, as defined below.
(c)Upon vesting, a number of Shares in Orion Engineered Carbons S.A. equal to the number of Restricted Stock Units that vest (or, at the Company’s election, an amount of cash equal to the Fair Market Value of such number of Shares) shall be delivered to Participant as soon as administratively feasible after the Vesting Date and in no event later than 45 days following the Vesting Date (the date the Shares are so delivered, the “Delivery Date”).




3.Forfeiture; Release.
(a)General. Except as otherwise provided in Section 2(b), if the Participant’s employment with the Company is terminated for any reason prior to the Scheduled Vesting Date, all Restricted Stock Units shall immediately be forfeited.
(b)Release. In the case of the Participant’s termination by the Company without Cause or by the Participant for Good Reason, the Participant shall, as a condition to receiving delivery of any Shares (or cash) under this Agreement, execute an agreement providing for a general release of claims in favor of the Company (the “Release”) and the Release must be executed by the Participant and become irrevocable prior to the date the delivery of Shares with respect to the Restricted Stock Units is scheduled to be made pursuant to Section 2(c); provided that if the Release is executed after such time, the Restricted Stock Units and any right to receive Shares or cash in respect thereof shall be forfeited.
4.Definitions.
(a)Cause” shall mean: (1) Participant’s conviction, whether following trial or by plea of guilty or nolo contendere (or similar plea), in a criminal proceeding (a) on a misdemeanor charge involving fraud, false statements or misleading omissions, wrongful taking, embezzlement, bribery, forgery, counterfeiting or extortion, or any other crime involving moral turpitude, (b) on a felony charge or (c) on an equivalent charge to those in clauses (a) and (b) in jurisdictions which do not use those designations; (2) continued material failure to perform Participant’s duties after notice from Orion; (3) engagement in illegal conduct or in gross misconduct, in either case, that causes financial or reputational harm to Orion, (4) material violation of the Orion’s codes of conduct or any other Orion policy as in effect from time to time, or (5) breach of any of the material terms of any other agreement between Participant and Orion.
(b)Disability” means a Participant’s incapacity due to physical or mental illness resulting in the Participant having been substantially unable to perform his or her duties hereunder for a continuous period of 180 days.
(c)Good Reason” shall mean that, with respect to Participant’s employment at Orion or its successors and without Participant’s consent, (1) Participant’s position, duties, or authority are materially diminished (2) Participant’s annual base salary is reduced or another element of Participant’s compensation is reduced or eliminated or (3) Participant’s primary work location is relocated to an office that is more than a hundred (100) miles from Houston or (4) breach of any material terms of this letter or any agreement between Participant and Orion. Notwithstanding the foregoing, an event will not constitute Good Reason unless (a) Participant gives a notice of termination within 90 days after Participant becomes



aware that an event constituting Good Reason has occurred describing in reasonable detail the event constituting Good Reason, and (b) Orion is given 30 days after it receives such notice from the Participant to cure such event and (c) Participant’s termination occurs no later than 30 days after Orion’s failure to cure such event.
(d) Dividends. The Participant shall not be entitled to receipt of any dividends or other distributions paid on Shares prior to the Delivery Date.
5.Adjustments. If any change is made to the outstanding Shares or the capital structure of the Company, the Restricted Stock Units will be adjusted as contemplated by Section 1.6.3 of the Omnibus Plan.
6.Withholding for Taxes. The delivery of Shares under this Plan is conditioned on the Participant’s satisfaction of any applicable taxes in accordance with Section 3.2 of the Omnibus Plan.
7.Clawback/Recapture Policy. The Restricted Stock Units shall be forfeited, and following the delivery of Shares (or cash), the Company shall be entitled to receive, and the Participant shall be obligated to repay the Company immediately upon demand therefor, the Fair Market Value of the Shares (determined as of the Scheduled Vesting Date) and the amount of cash (to the extent that any cash was delivered in lieu of Shares) delivered, net of any taxes withheld on the original payment to the Participant if, as determined by the Committee in its discretion:
(a)A material downward restatement of the Company’s financial statements with respect to any period between the Start Date and the final Vesting Date;
(b)The Participant violates any confidentiality, non-competition or non-solicitation obligation to the Company, including but not limited to those set forth in any employment agreement or offer letter between the Participant and the Company and/or Orion Engineered Carbons S.A.; or
(c)The Participant’s employment is terminated due to Cause that existed during the period between the Start Date and the final Vesting Date.
8.Rights as Stockholder. The Participant shall have no rights as a stockholder with respect to the Shares underlying the Restricted Stock Units granted under this Agreement unless and until the Restricted Stock Units vest and are settled by the issuance of such Shares.
9.Employment. Neither the granting of the Restricted Stock Units nor any term or provision of the Notice of Grant or this Agreement shall confer, constitute or be evidence of any understanding, express or implied, on the part of the Company or any of its subsidiaries to guarantee the Participant’s continued employment with the Company.



10.Disposition or Pledge of Restricted Stock Units.
(a)The Participant may not dispose (including pledge and otherwise encumber) of any unvested Restricted Stock Units, unless the Participant requests to do so in writing and the Committee consents to same in writing. The same applies to any transactions which, from an economic perspective, are similar to a disposition of unvested Restricted Stock Units.
(b)The Committee's consent to a disposal by a Participant to a legal entity controlled and solely represented by such Participant or to a member of his/her family shall not unreasonably be withheld.
11.Compliance with Securities Laws. The Company will not be required to deliver any certificates in respect of Restricted Stock Units pursuant to this Agreement, if, in the discretion of the Committee (or its delegate), such issuance would violate any applicable securities laws or stock exchange and other regulatory requirements. Prior to the vesting of or issuance of any certificates in respect of Restricted Stock Units pursuant to this Agreement, the Company may require that the Participant (or the Participant’s legal representative upon the Participants’ death or Disability, as applicable) enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable laws or with this Agreement.
12.Amendment. This Agreement may be amended by the Committee at any time, provided that, except as otherwise provided in the Director Plan, no such amendment, without the written consent of the Participant, shall materially adversely impair the rights of the Participant granted hereunder.
13.Miscellaneous.
(a)Compliance with Section 409A. The Restricted Stock Units are intended to be exempt from Section 409A, and this Agreement shall be interpreted, administered and construed to give effect to such intent. If any payment or delivery to be made under this Agreement would be subject to the limitations in Section 409A(a)(2)(B) of the Code, the payment or delivery will be delayed until six months after the Participant’s separation from service (or earlier death) in accordance with the requirements of Section 409A. Each payment or delivery under this Agreement will be treated as a separate payment or delivery for purposes of Section 409A.
(b)Headings. The headings in this Agreement are inserted for convenience only and shall have no significance in the interpretation of this Agreement.
(c)Entire Agreement. This Agreement, the Notice of Grant and the Omnibus Plan contain the entire agreement between the parties with respect to the transactions contemplated hereunder and supersede any prior arrangements or understandings with respect thereto, written or oral. No



agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement, including the Omnibus Plan and any and all attachments hereto.
(d)Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom the Restricted Stock Units may be transferred by will or the laws of descent and distribution.
(e)Repatriation. If the Participant is resident outside of the United States, the Participant agrees as a condition of the grant of the Restricted Stock Units to repatriate all payments attributable to the Restricted Stock Units acquired under the Omnibus Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Restricted Stock Units once vested) if required by and in accordance with local foreign exchange rules and regulations in the Participant’s country of residence. In addition, the Participant also agrees to take any and all actions, and consent to any and all actions taken by the Company and its subsidiaries, as may be required to allow the Company and its subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence. Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant’s country of residence.
(f)Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without reference to principles of conflict of laws.
(g)CONSENT TO JURISDICTION. BY ACCEPTING THIS AWARD, THE PARTICIPANT EXPRESSLY AND IRREVOCABLY AGREES TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL OR STATE COURT LOCATED IN NEW YORK, NEW YORK, U.S.A. IN RESPECT OF ANY MATTER HEREUNDER. This includes any action or proceeding to compel arbitration or to enforce an arbitration award.
(h)No Right to Future Grants.  The grant of the Restricted Stock Units is voluntary and does not create any contractual or other right to receive future grants of Restricted Stock Units, or benefits in lieu of Restricted Stock Units, even if Restricted Stock Units have been granted repeatedly in the past.  All decisions with respect to future grants, if any, will be at the sole discretion of the Committee. Notwithstanding any other agreement with the Participant, the Restricted Stock Units are not part of normal or expected compensation or salary for any purposes, including,



but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. The future value of the underlying Shares is unknown and cannot be predicted with certainty. No claim or entitlement to compensation or damages arises from forfeiture or termination of the Restricted Stock Units or diminution in value of the Restricted Stock Units or the underlying Shares and the Participant irrevocably releases the Committee, the Company and/or its subsidiaries (and their respective directors and officers) from any such claim that may arise.  The Omnibus Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, suspended or terminated by the Company at any time, as provided in the Omnibus Plan.  The Participant’s participation in the Omnibus Plan is voluntary. Any amendment, modification, or termination of the Omnibus Plan shall not constitute a change or impairment of the terms and conditions of the Participant’s employment with the Company and/or its subsidiaries.
14.Severability. The invalidity or unenforceability of any provision of the Omnibus Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Omnibus Plan or this Agreement.
15.Electronic Delivery.  The Company may, in its sole discretion, deliver any documents related to the Restricted Stock Units by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Omnibus Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
16.Employee Data Privacy.  The Participant hereby explicitly consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this document by and among, as applicable, the Company and its subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Omnibus Plan. The Participant understands that the Company holds certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Restricted Stock Units or any other entitlement, for the purpose of implementing, administering, and managing the Omnibus Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting the Company in the implementation, administration, and management of the Omnibus Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local Human Resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Omnibus Plan, including any requisite



transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Restricted Stock Units or Shares acquired. The Participant understands that Data will be held only as long as is necessary to implement, administer, and manage the Participant’s participation in the Omnibus Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local Human Resources representative. The Participant understands, however, that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Omnibus Plan (and may result in the forfeiture of unvested Restricted Stock Units). For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Company’s General Counsel or head of Human Resources.  
17.Acceptance. The Participant hereby acknowledges receipt of a copy of the Omnibus Plan and this Agreement. The Participant has read and understands the terms and provisions thereof, and accepts the Restricted Stock Units subject to all of the terms and conditions of the Omnibus Plan and this Agreement. The Participant acknowledges that there may be tax consequences upon the vesting or disposition of the Restricted Stock Units and that the Participant has been advised to consult a tax advisor prior to such vesting, settlement or disposition.
IN WITNESS WHEREOF, this Agreement has been executed by the Company and accepted by the Participant, effective as of the date first above written.

ORION ENGINEERED CARBONS LLC     


         
Name: Patrick F. Tuttle
Title: Senior Vice President, Global Human Resources



Read and Agreed:_____________________________ Date:___________________
Lorin James Crenshaw



ORION ENGINEERED CARBONS S.A.
FORM OF Performance Share Unit Award
Notice of Grant


PARTICIPANT NAME:  
PARTICIPANT ID:   
GRANT DATE:   
NUMBER OF UNITS:   

We are pleased to inform you that, pursuant to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, the Compensation Committee of the Board of Directors of Orion Engineered Carbons S.A. has made an award of Performance Share Units to you, subject to the terms and conditions set forth in the attached Award Agreement.
* * *





ORION ENGINEERED CARBONS S.A.
Performance Share Unit Award Agreement
This Performance Share Unit Award Agreement (this “Agreement”) is entered into by and between Orion Engineered Carbons S.A. (the “Company”) and you (the “Participant”) pursuant and subject to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, as may be amended from time to time (the “Omnibus Plan”). All capitalized terms not defined in this Agreement shall have the meaning stated in the Omnibus Plan. If there is any inconsistency or conflict between the terms of this Agreement and the terms of the Omnibus Plan, the terms of the Omnibus Plan shall control and govern unless this Agreement expressly states that an exception to the Omnibus Plan is being made.
1.Grant of Performance Share Units. The Company hereby grants to the Participant the number of performance share units (the “Units”) set forth in the Notice of Grant (such number of Units, the “Target Units”). Each Unit constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered) one Share (or, at the election of the Company, cash equal to the Fair Market Value thereof) as provided herein.
2.Performance Conditions.
(a)The Units shall be earned based on performance achieved over a three-year period beginning on [_____] and ending on [______] (the “Performance Period”). The number of Units earned, if any, is subject to increase or decrease based on the Company’s actual performance against the Company performance goals set forth in Schedule A to this Agreement and may range from 0% to 200% of the Target Units.
(b)Following the end of the Performance Period and no later than seventy-five (75) days thereafter, the Committee will determine the number of Target Units that have been earned (the “Earned Units”) in accordance with Schedule A. For the avoidance of doubt, the number of Earned Units may be zero. The date the Committee determines the number of Earned Units is the “Determination Date.” Determinations of whether the performance goals have been achieved, the number of Units earned by the Participant, and all other matters related to this Section 2 shall be made by the Compensation Committee of the Board of Directors of the Company (the “Committee”) in its sole discretion. 
3.Vesting; Settlement. The Units are subject to forfeiture until they vest. Except as otherwise provided herein, the Units will vest as to the service-based conditions and become non-forfeitable subject to continued employment through last day of the Performance Period (the “Scheduled Vesting Date”), and subject to the Committee’s certification of the achievement of the performance goals in Schedule A in accordance with Section 2. Each Earned Unit shall be settled by
        -1-

June 25, 2109


delivery of a Share (or, at the Company’s election, an amount of cash equal to the Fair Market Value of one Share) as soon as administratively feasible after the Determination Date and in no event later than seventy-five (75) days following the Scheduled Vesting Date (the date the Shares (or cash) are so settled, the “Delivery Date”).
4.Termination of Employment.
(a)General. Except as otherwise provided in this Section 4, if the Participant’s employment with the Company is terminated for any reason prior to the Scheduled Vesting Date, all Units shall immediately be forfeited.
(b)Death; Disability; Involuntary Termination. If any one of the following events occurs on or prior to the Scheduled Vesting Date: (1) the Participant’s death, (2) the Participant’s termination due to Disability, (3) termination by the Company without Cause, or (4) a resignation by the Participant with Good Reason, then the Earned Units (if any) shall equal the number of Units the Participant would have vested in if the Participant remained employed through the Scheduled Vesting Date, as determined on the Determination Date, pro-rated by multiplying that number of Units by a fraction, the numerator of which is the number of full or partial months elapsed since the first date of the Performance Period to the date of termination and the denominator of which is 36. Following the Determination Date, the pro-rated Earned Units shall be settled in accordance with Section 3.
(c)Retirement. If the Participant’s employment terminates due to Retirement or Early Retirement prior to the Scheduled Vesting Date and if the Participant has worked at least one year since the beginning of the Performance Period, then the Earned Units (if any) shall equal the number of Units the Participant would have vested in if the Participant remained employed through the Scheduled Vesting Date, pro-rated by multiplying that number of Units by a fraction, the numerator of which is the number of full or partial months elapsed since the first day of the Performance Period to the date of termination and the denominator of which is 36. Following the Determination Date, the Earned Units shall be settled in accordance with Section 3. If the Participant has worked less than one year since the beginning of the Performance Period and employment terminates due to Retirement or Early Retirement within that first year, all Units hereunder forfeit entirely.
(d)Release; Restrictive Covenants. In the case of the Participant’s termination by the Company without Cause, resignation with Good Reason, Early Retirement or Retirement, the Company will require the Participant to execute an agreement providing for a general release of claims in favor of the Company and, to the extent permitted by applicable local laws, restrictive covenants requiring confidentiality of information following the termination and non-competition with the Company and non-solicitation of Company employees for twelve months following the termination (the “Release”) as a condition to receiving delivery of any Shares (or cash) under this Agreement, and the Release must be executed by the Participant and become irrevocable within thirty (30) days following the
        -2-




termination date, or such longer period as may be required by law or as needed per local norms outsides of the United States; provided that if the Release is executed after such time, the Earned Units will be forfeited.
5.   Change in Control.
i.Performance Determination. Unless otherwise determined by the Committee, in the event of a Change in Control prior to the end of the Performance Period, the Committee shall, in its sole discretion, adjust the performance goals set forth in Schedule A to account for a shortened performance period through the date of the Change in Control and determine the Earned Units based on actual performance against such adjusted goals through the date of the Change in Control (such Units, the “CIC Earned Units”).
ii.Vesting. Unless otherwise determined by the Committee, any CIC Earned Units shall vest and become non-forfeitable on the earlier of the Scheduled Vesting Date and the one-year anniversary of the Change in Control. All CIC Earned Units shall be forfeited if the Participant’s employment with the Company (or successor thereto) is terminated for any reason prior to the one-year anniversary of the Change in Control other than a termination by reason of one of the following events: (1) the Participant’s death, (2) the Participant’s termination due to Disability, (3) a termination by the Company (or successor thereto) without Cause or (4) a resignation by the Participant with Good Reason, in which case the Participant will immediately vest in the CIC Earned Units. Each CIC Earned Unit shall be settled by delivery of a Share (or, at the Company’s election, an amount of cash equal to the Fair Market Value of one Share) as soon as administratively feasible after vesting and in no event later than seventy-five (75) days following vesting date.
iii.Change in Control After Performance Period. In the event of a Change in Control after the end of the Performance Period but prior to the Delivery Date, the Earned Units shall be determined and settled in accordance with Section 2 and Section 3 of this Agreement.
(e)Dividends. The Participant shall not be entitled to receipt of any dividends or other distributions paid on Shares prior to the Scheduled Vesting Date and delivery of Shares in settlement of any Earned Units.
(f)Adjustments. If any change is made to the outstanding Shares or the capital structure of the Company, the Units will be adjusted as contemplated by Section 1.6.3 of the Omnibus Plan.
(g)Withholding for Taxes. The delivery of Shares (or cash) under this Plan is conditioned on the Participant’s satisfaction of any applicable taxes in accordance with Section 3.2 of the Omnibus Plan.
(h)Clawback/Recapture Policy. The Units shall be forfeited, and following the delivery of Shares (or cash), the Company shall be entitled to receive, and the
        -3-




Participant shall be obligated to repay the Company immediately upon demand therefor, the Fair Market Value of the Shares (determined as of the Delivery Date) and the amount of cash (to the extent that any cash was delivered in lieu of Shares) delivered, net of any taxes withheld on the original payment to the Participant if, as determined by the Committee in its discretion:
i.A material downward restatement of the Company’s historical Total Shareholder Return (defined in accordance with Schedule A) occurs with respect to the Performance Period;
ii.The Participant violates any confidentiality, non-competition or non-solicitation obligations, including but not limited to those set forth in any Release; or
iii.The Participant’s employment is terminated due to Cause that existed during the Performance Period.
5.Rights as Stockholder. The Participant shall have no rights as a stockholder with respect to the Shares underlying the Units granted under this Award unless and until the Units vest and are settled by the issuance of such Shares.
6.Employment. Neither the granting of the Units nor any term or provision of the Notice of Grant or this Agreement shall confer, constitute or be evidence of any understanding, express or implied, on the part of the Company or any of its subsidiaries to guarantee the Participant’s continued employment with the Company.
7.Disposition or Pledge of Units.
(a)The Participant may not dispose (including pledge and otherwise encumber) of the Units, unless the Participant makes request to do so in writing and the Committee consents to same in writing. The same applies to any transactions which, from an economic perspective, are similar to a disposition of the Units.
(b)The Committee's consent to a disposal by a Participant to a legal entity controlled and solely represented by such Participant or to a member of his/her family shall not unreasonably be withheld.
13. Compliance with Securities Laws. The Company will not be required to deliver any Shares pursuant to this Agreement, if, in the discretion of the Committee (or its delegate), such issuance would violate any applicable securities laws or stock exchange and other regulatory requirements. Prior to the issuance of any Shares pursuant to this Agreement, the Company may require that the Participant (or the Participant’s legal representative upon the Participants’ death or Disability, as applicable) enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable laws or with this Agreement.
        -4-




14. Amendment. This Agreement may be amended by the Committee at any time, provided that, except as otherwise provided in the Omnibus Plan, no such amendment, without the written consent of the Participant, shall materially adversely impair the rights of the Participant granted hereunder.
15.Miscellaneous.
i.Compliance with Section 409A. The Units are intended to be exempt from or comply with Section 409A, and this Agreement shall be interpreted, administered and construed to give effect to such intent. It is the intention of the Company and the Participant that this Agreement not result in unfavorable tax consequences to the Participant under Section 409A, and shall be interpreted and administered to give effect to that intent. Accordingly, the Participant consents to any amendment of this Agreement as the Company may reasonably make in furtherance of such intention, and the Company shall promptly provide, or make available to, the Participant a copy of such amendment. Any such amendment shall be made in a manner that preserves to the maximum extent possible the intended benefits to the Participant. This Section 15.a does not create an obligation on the part of Company to modify this Agreement and does not guarantee that the amounts or benefits owed under the Agreement will not be subject to interest and penalties under Section 409A. If any payment or delivery to be made under this Agreement would be subject to the limitations in Section 409A(a)(2)(B) of the Code, the payment or delivery will be delayed until six months after the Participant’s separation from service (or earlier death) in accordance with the requirements of Section 409A. Each payment or delivery under this Agreement will be treated as a separate payment or delivery for purposes of Section 409A.
(c)Headings. The headings in this Agreement are inserted for convenience only and shall have no significance in the interpretation of this Agreement.
(d)Entire Agreement. This Agreement, the Notice of Grant, Schedule A, which is attached hereto and shall be deemed to be a part of this Agreement, the Omnibus Plan, and any and all other attachments hereto, contain the entire agreement between the parties with respect to the transactions contemplated hereunder and supersede any prior arrangements or understandings with respect thereto, written or oral. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement, including the Omnibus Plan and any and all attachments hereto.
(e)Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom the Units may be transferred by will or the laws of descent and distribution.

        -5-




(f)Repatriation. If the Participant is resident or employed outside of the United States, the Participant agrees as a condition of the grant of the Units to repatriate all payments attributable to the Shares and/or cash acquired under the Omnibus Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the Units) if required by and in accordance with local foreign exchange rules and regulations in the Participant’s country of residence (and country of employment, if different). In addition, the Participant also agrees to take any and all actions, and consent to any and all actions taken by the Company and its subsidiaries, as may be required to allow the Company and its subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence (and country of employment, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant’s country of residence (and country of employment, if different).
(g)Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without reference to principles of conflict of laws.
(h)CONSENT TO JURISDICTION. BY ACCEPTING THIS AWARD, THE PARTICIPANT EXPRESSLY AND IRREVOCABLY AGREES TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL OR STATE COURT LOCATED IN NEW YORK, NEW YORK, U.S.A. IN RESPECT OF ANY MATTER HEREUNDER. This includes any action or proceeding to compel arbitration or to enforce an arbitration award.
(i)No Right to Future Grants.  The grant of the Units is voluntary and does not create any contractual or other right to receive future grants of Units, or benefits in lieu of Units, even if Units have been granted repeatedly in the past.  All decisions with respect to future grants, if any, will be at the sole discretion of the Committee. Notwithstanding any other agreement with the Participant, the Units are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. The future value of the underlying Shares is unknown and cannot be predicted with certainty. No claim or entitlement to compensation or damages arises from forfeiture or termination of the Units or diminution in value of the Units or the underlying Shares and the Participant irrevocably releases the Committee, the Company and/or its subsidiaries (and their respective directors and officers) from any such claim that may arise.  The Omnibus Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, suspended or terminated by the Company at any time, as provided in the Omnibus Plan.  The Participant’s participation in the Omnibus Plan is voluntary. Any amendment, modification, or termination of the Omnibus Plan shall not constitute a change or impairment of
        -6-




the terms and conditions of the Participant’s employment with the Company and/or its subsidiaries.

(j)Employee Data Privacy.  The Participant hereby explicitly consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this document by and among, as applicable, the Company and its subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Omnibus Plan. The Participant understands that the Company holds certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Units or any other entitlement, for the purpose of implementing, administering, and managing the Omnibus Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting the Company in the implementation, administration, and management of the Omnibus Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local Human Resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Omnibus Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Shares acquired. The Participant understands that Data will be held only as long as is necessary to implement, administer, and manage the Participant’s participation in the Omnibus Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local Human Resources representative. The Participant understands, however, that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Omnibus Plan (and may result in the forfeiture of unvested Units). For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Participant’s local Human Resources representative.  
16.Addendum to Agreement. Notwithstanding any provisions of this Agreement to the contrary, the Units shall be subject to such special terms and conditions for the Participant’s country of residence (and country of employment, if different), as are set forth in the addendum to this Agreement (the “Addendum”), if any. Further, if the Participant transfers residency and/or employment to another country, any special terms and conditions for such country will apply to the Units to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local
        -7-




law or to facilitate the operation and administration of the Units and the Omnibus Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate the Participant’s transfer). In all circumstances, the Addendum shall constitute part of this Agreement.
17.Severability. The invalidity or unenforceability of any provision of the Omnibus Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Omnibus Plan or this Agreement.
18.Electronic Delivery.  The Company may, in its sole discretion, deliver any documents related to the Units awarded under this Agreement or the Omnibus Plan by electronic means or request the Participant’s consent to participate in the administration of this Agreement and the Omnibus Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Omnibus Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
19.Acceptance. The Participant hereby acknowledges receipt of a copy of the Omnibus Plan and this Agreement. The Participant has read and understands the terms and provisions thereof, and accepts the Units subject to all of the terms and conditions of the Omnibus Plan and this Agreement. The Participant acknowledges that there may be tax consequences upon the vesting or settlement of the Units or disposition of the underlying Shares and that the Participant has been advised to consult a tax advisor prior to such vesting, settlement or disposition.
IN WITNESS WHEREOF, this Agreement has been executed by the Company and accepted by the Participant, effective as of the date first above written.

ORION ENGINEERED CARBONS S.A.

         
Name:  
Title:  

Attachments:  Definitions Annex










        -8-




DEFINITIONS ANNEX

Cause” means, unless otherwise defined in an employment agreement between the Participant and the Company, the Participant’s (i) conviction, whether following trial or by plea of guilty or nolo contendere (or similar plea), in a criminal proceeding (a) on a misdemeanor charge involving fraud, false statements or misleading omissions, wrongful taking, embezzlement, bribery, forgery, counterfeiting or extortion, or any other crime involving moral turpitude, (b) on a felony charge or (c) on an equivalent charge to those in clauses (a) and (b) in jurisdictions which do not use those designations; (ii) engagement in any conduct which constitutes an employment disqualification under applicable local laws, bylaws, statutes, regulations, codes of practice or applicable guidance issued by a governmental department or regulatory authority applicable to the country of such Participant’s primary work location; (iii) continued material failure to perform his or her duties after notice from the Company; (iv) engagement in illegal conduct or in gross misconduct, in either case, that causes financial or reputational harm to the Company, (v) material violation of the Company’s codes of conduct or any other Company policy as in effect from time to time or (vi) breach of any of the material terms of the Omnibus Plan, this Agreement or any other agreement between the Participant and the Company or any of its affiliates. The determination as to whether Cause has occurred will be made by the Committee in its sole discretion. The Committee will also have the authority in its sole discretion to waive the consequences of the existence or occurrence of any of the events, acts or omissions constituting Cause.
Disability” means that the Participant is determined to have a medically determinable physical or mental impairment which renders the Participant unable to perform employment duties and which can be expected to result in death or can be expected to last for a continuous period of not less than six (6) months.
Early Retirement” means the Participant’s resignation of employment (while in good standing with the Company) on or after age fifty-five (55) years and having at least five (5) consecutive years of active employment service with the Company.
Good Reason” means, unless otherwise defined in an employment agreement between the Participant and the Company, without the Participant’s consent, (i) a material diminution in the Participant’s annual base salary, (ii) a material diminution in the Participant’s position, duties and authority, or (iii) the Company moves the Participant’s work location by more than 100 miles. Notwithstanding the foregoing, an event will not constitute Good Reason unless (a) the Participant gives a notice of termination within 90 days after the Participant becomes aware that an event constituting Good Reason has occurred describing in reasonable detail the event constituting Good Reason, and (b) the Company is given 30 days after the Company receives notice from the Participant of the event purporting to constitute Good Reason to cure such event. In addition, the Participant’s termination of employment must occur no later than 30 days after the Company’s failure to cure the Good Reason event provided in the notice.
Normal Retirement Age” means, unless otherwise determined by the Committee, the applicable statutory retirement age in the country of the Participant’s primary work location or, if no such statutory retirement age exists, age sixty-five (65).
Retirement” means the Participant’s resignation of employment (while in good standing with the Company) on or after Normal Retirement Age or such earlier date as determined by the Committee in its discretion.
        -9-




ORION ENGINEERED CARBONS S.A.
ADDENDUM TO
PERFORMANCE SHARE UNIT AWARD AGREEMENT


The Units are subject to the following additional terms and conditions as set forth in this addendum (the “Addendum”). All defined terms as contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement. Pursuant to Section Error! Reference source not found.5 of the Agreement, to the extent the Participant relocates residence and/or employment to another country, the additional terms and conditions as set forth in the addendum for such country (if any) shall also apply to the Units to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local laws, rules and regulations, or to facilitate the operation and administration of the Units and the Plan (or the Company may establish additional special terms and conditions as may be necessary or advisable to accommodate the Participant’s transfer).
        -10-



ORION ENGINEERED CARBONS S.A.
FORM OF Restricted Stock Unit Award
Notice of Grant


PARTICIPANT NAME:    
PARTICIPANT ID:     
GRANT DATE:
NUMBER OF RESTRICTED STOCK UNITS:  

We are pleased to inform you that, pursuant to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, you have been made an award of Restricted Stock Units, subject to the terms and conditions set forth in the attached Award Agreement.
* * *






* * *
ORION ENGINEERED CARBONS S.A.
Restricted Stock Unit
Award Agreement

This Restricted Stock Unit Award Agreement (this “Agreement”) is entered into by and between Orion Engineered Carbons S.A. (the “Company”) and you (the “Participant”) pursuant and subject to the Orion Engineered Carbons S.A. 2014 Omnibus Incentive Compensation Plan, as may be amended from time to time (the “Omnibus Plan”). All capitalized terms not defined in this Agreement shall have the meaning stated in the Omnibus Plan. If there is any inconsistency or conflict between the terms of this Agreement and the terms of the Omnibus Plan, the terms of the Omnibus Plan shall control and govern unless this Agreement expressly states that an exception to the Omnibus Plan is being made.
1.Grant of Restricted Stock Units. On the terms and conditions set forth below, the Company hereby grants to the Participant the number of restricted stock units set forth in the Notice of Grant (such number of restricted stock units, the “Restricted Stock Units”). Each Unit constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered) one Share (or, at the election of the Company, cash equal to the Fair Market Value thereof) as provided herein.
2.[INTENTIONALLY BLANK]
3.Vesting; Settlement. The Restricted Stock Units are subject to forfeiture until they vest. One-third of the Restricted Stock Units will vest and become non-forfeitable on each of [______] (each anniversary, a “Scheduled Vesting Date”), subject to the Participant’s service as an employee of the Company through the applicable Scheduled Vesting Date. Except as otherwise provided in Section 3, each Restricted Stock Unit shall be settled by delivery of a Share (or, at the Company’s election, an amount of cash equal to the Fair Market Value of one Share) as soon as administratively feasible after the [applicable][final] Scheduled Vesting Date and in no event later than seventy-four (74) days following such date (the date of delivery of Shares (or cash) in respect of settlement, the “Delivery Date”).

1



4.Termination of Employment.
(a)General. Except as otherwise provided in this Section 4, if the Participant’s employment with the Company is terminated for any reason prior to the Delivery Date, all Restricted Stock Units not yet vested shall immediately be forfeited.
(b)Death; Disability; Involuntary Termination. If any one of the following events occurs on or prior to the Delivery Date: (1) the Participant’s death, (2) the Participant’s termination due to Disability, (3) termination by the Company without Cause or (4) a resignation by the Participant with Good Reason, then the vested Restricted Stock Units shall be settled in accordance with Section 3.
(c)Retirement. If the Participant’s employment terminates due to Retirement or Early Retirement prior to the final Scheduled Vesting Date and if the Participant has worked at least one year since the Grant Date, then the Participant shall become immediately vested in a prorated portion of the Units that the Participant would have vested in if the Participant remained employed through the next Scheduled Vesting Date, calculated by multiplying the total number of Units granted hereunder by a fraction, the numerator of which is the number of full or partial months elapsed since January 1 of year of termination to the date of termination and the denominator of which is 36. Following the Retirement or Early Retirement, the vested Units in accordance with the foregoing shall be settled in accordance with Section 3. If the Participant has worked less than one year and the Participant’s employment terminates due to Retirement or Early Retirement within that first year and prior to any Scheduled Vesting Date, all Units hereunder forfeit entirely.
(d)Release; Restrictive Covenants. In the case of the Participant’s termination by the Company without Cause, resignation with Good Reason, Retirement or Early Retirement, the Company will require the Participant to execute an agreement providing for a general release of claims in favor of the Company and, to the extent permitted by applicable local laws, restrictive covenants requiring confidentiality of information following the termination and non-competition with the Company and non-solicitation of Company employees for twelve months following the termination (the “Release”) as a condition to receiving delivery of any Shares (or cash) under this Agreement in respect of vested Restricted Stock Units, and the Release must be executed by the Participant and become irrevocable within thirty (30) days of the termination of employment, or such longer period as may be required by law or as needed per local norms outsides of the United States; provided that if the Release is executed after such time, any vested Restricted Stock Units that have not yet been settled, will be forfeited.
5.Dividends. The Participant shall not be entitled to receipt of any dividends or other distributions paid on Shares prior to the Scheduled Vesting Date and settlement of Restricted Stock Units in Shares.
2



6.Adjustments. If any change is made to the outstanding Shares or the capital structure of the Company, the Restricted Stock Units will be adjusted as contemplated by Section 1.6.3 of the Omnibus Plan.
7.Withholding for Taxes. The delivery of Shares under this Plan is conditioned on the Participant’s satisfaction of any applicable taxes in accordance with Section 3.2 of the Omnibus Plan.
8.Clawback/Recapture Policy. The Restricted Stock Units shall be forfeited, and following the delivery of Shares (or cash), the Company shall be entitled to receive, and the Participant shall be obligated to repay the Company immediately upon demand therefor, the Fair Market Value of the Shares (determined as of the Delivery Date) and the amount of cash (to the extent that any cash was delivered in lieu of Shares) delivered, net of any taxes withheld on the original payment to the Participant if, as determined by the Committee in its discretion:
(i)The Participant violates any confidentiality, non-competition or non-solicitation obligation to the Company, including but not limited to those set forth in any employment agreement or offer letter between the Participant and the Company and/or Orion Engineered Carbons S.A.; or
(ii)The Participant’s employment is terminated due to Cause that existed during the period between the Grant Date and the final Scheduled Vesting Date.
9.Rights as Stockholder. The Participant shall have no rights as a stockholder with respect to the Shares underlying the Restricted Stock Units granted under this Agreement unless and until the Restricted Stock Units vest and are settled by the issuance of such Shares.
10.Employment. Neither the granting of the Restricted Stock Units nor any term or provision of the Notice of Grant or this Agreement shall confer, constitute or be evidence of any understanding, express or implied, on the part of the Company or any of its subsidiaries to guarantee the Participant’s continued employment with the Company.
11.Disposition or Pledge of Restricted Stock Units.
(iii)The Participant may not dispose (including pledge and otherwise encumber) of any unvested Restricted Stock Units, unless the Participant requests to do so in writing and the Committee consents to same in writing. The same applies to any transactions which, from an economic perspective, are similar to a disposition of unvested Restricted Stock Units.
(iv)The Committee's consent to a disposal by a Participant to a legal entity controlled and solely represented by such Participant or to a member of his/her family shall not unreasonably be withheld.
3



Compliance with Securities Laws. The Company will not be required to deliver any certificates in respect of Shares issued in settlement of Restricted Stock Units pursuant to this Agreement, if, in the discretion of the Committee (or its delegate), such issuance would violate any applicable securities laws or stock exchange and other regulatory requirements. Prior to the settlement of or issuance of any certificates in respect of Shares delivered in settlement of Restricted Stock Units pursuant to this Agreement, the Company may require that the Participant (or the Participant’s legal representative upon the Participants’ death or Disability, as applicable) enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable laws or with this Agreement.
12.Amendment. This Agreement may be amended by the Committee at any time, provided that, except as otherwise provided in the Director Plan, no such amendment, without the written consent of the Participant, shall materially adversely impair the rights of the Participant granted hereunder.
13.Miscellaneous.
(v)Compliance with Section 409A. The Restricted Stock Units are intended to be exempt from or comply with Section 409A, and this Agreement shall be interpreted, administered and construed to give effect to such intent. If any payment or delivery to be made under this Agreement would be subject to the limitations in Section 409A(a)(2)(B) of the Code, the payment or delivery will be delayed until six months after the Participant’s separation from service (or earlier death) in accordance with the requirements of Section 409A. Each payment or delivery under this Agreement will be treated as a separate payment or delivery for purposes of Section 409A.
(vi)Headings. The headings in this Agreement are inserted for convenience only and shall have no significance in the interpretation of this Agreement.
(vii)Entire Agreement. This Agreement, the Notice of Grant and the Omnibus Plan contain the entire agreement between the parties with respect to the transactions contemplated hereunder and supersede any prior arrangements or understandings with respect thereto, written or oral. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement, including the Omnibus Plan and any and all attachments hereto.
(viii)Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom the Restricted Stock Units may be transferred by will or the laws of descent and distribution.
4



(ix)Repatriation. If the Participant is resident outside of the United States, the Participant agrees as a condition of the grant of the Restricted Stock Units to repatriate all payments attributable to the Restricted Stock Units acquired under the Omnibus Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Restricted Stock Units once vested) if required by and in accordance with local foreign exchange rules and regulations in the Participant’s country of residence. In addition, the Participant also agrees to take any and all actions, and consent to any and all actions taken by the Company and its subsidiaries, as may be required to allow the Company and its subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence. Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant’s country of residence.
(x)Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without reference to principles of conflict of laws.
(xi)CONSENT TO JURISDICTION. BY ACCEPTING THIS AWARD, THE PARTICIPANT EXPRESSLY AND IRREVOCABLY AGREES TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL OR STATE COURT LOCATED IN NEW YORK, NEW YORK, U.S.A. IN RESPECT OF ANY MATTER HEREUNDER. This includes any action or proceeding to compel arbitration or to enforce an arbitration award.
(xii)No Right to Future Grants. The grant of the Restricted Stock Units is voluntary and does not create any contractual or other right to receive future grants of Restricted Stock Units, or benefits in lieu of Restricted Stock Units, even if Restricted Stock Units have been granted repeatedly in the past.  All decisions with respect to future grants, if any, will be at the sole discretion of the Committee. Notwithstanding any other agreement with the Participant, the Restricted Stock Units are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. The future value of the underlying Shares is unknown and cannot be predicted with certainty. No claim or entitlement to compensation or damages arises from forfeiture or termination of the Restricted Stock Units or diminution in value of the Restricted Stock Units or the underlying Shares and the Participant irrevocably releases the Committee, the Company and/or its subsidiaries (and their respective directors and officers) from any such claim that may arise. The Omnibus Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, suspended or terminated by the Company at any time, as provided in the Omnibus Plan.  The
5



Participant’s participation in the Omnibus Plan is voluntary. Any amendment, modification, or termination of the Omnibus Plan shall not constitute a change or impairment of the terms and conditions of the Participant’s employment with the Company and/or its subsidiaries.
14.Severability. The invalidity or unenforceability of any provision of the Omnibus Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Omnibus Plan or this Agreement.
15.Electronic Delivery. The Company may, in its sole discretion, deliver any documents related to the Restricted Stock Units by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Omnibus Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
16.Employee Data Privacy. The Participant hereby explicitly consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this document by and among, as applicable, the Company and its subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Omnibus Plan. The Participant understands that the Company holds certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Restricted Stock Units or any other entitlement, for the purpose of implementing, administering, and managing the Omnibus Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting the Company in the implementation, administration, and management of the Omnibus Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local Human Resources representative. The Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Omnibus Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Restricted Stock Units or Shares acquired. The Participant understands that Data will be held only as long as is necessary to implement, administer, and manage the Participant’s participation in the Omnibus Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local Human Resources representative. The Participant understands, however, that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Omnibus Plan (and may result in the forfeiture of unvested Restricted Stock Units). For more information on the consequences of the Participant’s refusal to consent or
6



withdrawal of consent, the Participant understands that the Participant may contact the Company’s General Counsel or head of Human Resources.
17.Acceptance. The Participant hereby acknowledges receipt of a copy of the Omnibus Plan and this Agreement. The Participant has read and understands the terms and provisions thereof, and accepts the Restricted Stock Units subject to all of the terms and conditions of the Omnibus Plan and this Agreement. The Participant acknowledges that there may be tax consequences upon the vesting or disposition of the Restricted Stock Units and that the Participant has been advised to consult a tax advisor prior to such vesting, settlement or disposition.
IN WITNESS WHEREOF, this Agreement has been executed by the Company and accepted by the Participant, effective as of the date first above written.

ORION ENGINEERED CARBONS S.A.     


         
Name: 
Title: 

Attachments:  Definitions Annex
Addendum to Restricted Stock Unit Award Agreement


7



DEFINITIONS ANNEX

Cause” means, unless otherwise defined in an employment agreement between the Participant and the Company, the Participant’s (i) conviction, whether following trial or by plea of guilty or nolo contendere (or similar plea), in a criminal proceeding (a) on a misdemeanor charge involving fraud, false statements or misleading omissions, wrongful taking, embezzlement, bribery, forgery, counterfeiting or extortion, or any other crime involving moral turpitude, (b) on a felony charge or (c) on an equivalent charge to those in clauses (a) and (b) in jurisdictions which do not use those designations; (ii) engagement in any conduct which constitutes an employment disqualification under applicable local laws, bylaws, statutes, regulations, codes of practice or applicable guidance issued by a governmental department or regulatory authority applicable to the country of such Participant’s primary work location; (iii) continued material failure to perform his or her duties after notice from the Company; (iv) engagement in illegal conduct or in gross misconduct, in either case, that causes financial or reputational harm to the Company, (v) material violation of the Company’s codes of conduct or any other Company policy as in effect from time to time or (vi) breach of any of the material terms of the Omnibus Plan, this Agreement or any other agreement between the Participant and the Company or any of its affiliates. The determination as to whether Cause has occurred will be made by the Committee in its sole discretion. The Committee will also have the authority in its sole discretion to waive the consequences of the existence or occurrence of any of the events, acts or omissions constituting Cause.
Disability” means that the Participant is determined to have a medically determinable physical or mental impairment which renders the Participant unable to perform employment duties and which can be expected to result in death or can be expected to last for a continuous period of not less than six (6) months.
Early Retirement” means the Participant’s resignation of employment (while in good standing with the Company) on or after age fifty-five (55) years and having at least five (5) consecutive years of active employment service with the Company.
Good Reason” means, unless otherwise defined in an employment agreement between the Participant and the Company, without the Participant’s consent, (i) a material diminution in the Participant’s annual base salary, (ii) a material diminution in the Participant’s position, duties and authority, or (iii) the Company moves the Participant’s work location by more than 100 miles. Notwithstanding the foregoing, an event will not constitute Good Reason unless (a) the Participant gives a notice of termination within 90 days after the Participant becomes aware that an event constituting Good Reason has occurred describing in reasonable detail the event constituting Good Reason, and (b) the Company is given 30 days after the Company receives notice from the Participant of the event purporting to constitute Good Reason to cure such event. In addition, the Participant’s termination of employment must occur no later than 30 days after the Company’s failure to cure the Good Reason event provided in the notice.
Normal Retirement Age” means, unless otherwise determined by the Committee, the applicable statutory retirement age in the country of the Participant’s primary work location or, if no such statutory retirement age exists, age sixty-five (65).
Retirement” means the Participant’s resignation of employment (while in good standing with the Company) on or after Normal Retirement Age or such earlier date as determined by the Committee in its discretion.
8






ORION ENGINEERED CARBONS S.A.
ADDENDUM TO
RESTRICTED STOCK UNIT AWARD AGREEMENT


The Units are subject to the following additional terms and conditions as set forth in this addendum (the “Addendum”). All defined terms as contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement. Pursuant to Section 15 of the Agreement, to the extent the Participant relocates residence and/or employment to another country, the additional terms and conditions as set forth in the addendum for such country (if any) shall also apply to the Units to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local laws, rules and regulations, or to facilitate the operation and administration of the Units and the Plan (or the Company may establish additional special terms and conditions as may be necessary or advisable to accommodate the Participant’s transfer).

9


ORION ENGINEERED CARBONS S.A.
FORM OF Non-Employee Director Restricted Share Award
Notice of Grant


PARTICIPANT NAME:  _____________
PARTICIPANT ID:   Director
GRANT DATE:   _____________
NUMBER OF RESTRICTED SHARES:1  _____________

We are pleased to inform you that, pursuant to the Orion Engineered Carbons S.A. ____ Non-Employee Director Plan, you have been made an award of restricted shares, subject to the terms and conditions set forth in the attached Award Agreement.
* * *
ORION ENGINEERED CARBONS S.A.
Non-Employee Director Restricted Share
Award Agreement

This Restricted Share Award Agreement (this “Agreement”) is entered into by and between Orion Engineered Carbons S.A. (the “Company”) and you (the “Participant”) pursuant and subject to the Orion Engineered Carbons S.A. ____ Non-Employee Director Plan, as may be amended from time to time (the “Director Plan”). All capitalized terms not defined in this Agreement shall have the meaning stated in the Director Plan. If there is any inconsistency or conflict between the terms of this Agreement and the terms of the Director Plan, the terms of the Director Plan shall control and govern unless this Agreement expressly states that an exception to the Director Plan is being made.
1.Grant of Restricted Shares. On the terms and conditions set forth below, the Company hereby grants to the Participant the number of Shares set forth in the Notice of Grant (such number of Shares, the “Restricted Shares”).
2.Vesting; Settlement.
(a)The Restricted Shares are subject to forfeiture until they vest. The Restricted Shares will vest and become non-forfeitable on the first anniversary of the Grant Date set forth in the Notice of Grant (the “Scheduled Vesting Date”), subject to the Participant’s service as a
        -1-
SC1:4610533.3


member of the Company’s Board of Directors through the Scheduled Vesting Date.
(b)Unless otherwise determined by the Committee, any Restricted Shares shall vest and become non-forfeitable on the occurrence of a Change in Control (the earliest to occur of the Scheduled Vesting Date or the date a Change in Control occurs, the “Vesting Date”).
(c)Upon vesting, restrictions on each Restricted Share shall lapse and if the Restricted Shares are certificated as set forth in Section 2.5.1 of the Director Plan, such certificate will be registered in the Participant’s name and delivered to Participant as soon as administratively feasible after the Vesting Date and in no event later than 30 days following the Vesting Date (the date the Restricted Shares are so settled, the “Delivery Date”).
3.Forfeiture. If the Participant ceases to serve as a member of the Company’s Board of Directors at any time prior to the Vesting Date for any reason, the Restricted Shares shall, and any accrued but unpaid dividends that are at the time subject to restrictions set forth herein shall, be forfeited and returned to the Company without consideration.
4.Rights as a Stockholder; Dividends.
(a)From and after the Grant Date and for so long as the Restricted Shares are held by or for the benefit of the Participant, the Participant shall have all the rights of a shareholder of the Company with respect to the Restricted Shares, including but not limited to the right to receive dividends and the right to vote such Restricted Shares, in accordance with Section 2.5.2 of the Director Plan.
(b)Notwithstanding the foregoing, any dividends that are to be paid in respect of Restricted Shares during the period from the Grant Date until the Vesting Date shall accrue and be paid on the Delivery Date, or promptly thereafter unless the Restricted Shares are earlier forfeited in accordance with Section 3.
5.Adjustments. If any change is made to the outstanding Shares or the capital structure of the Company, the Restricted Shares will be adjusted as contemplated by Section 1.6.3 of the Director Plan.
6.Disposition or Pledge of Restricted Shares.
(a)The Participant may not dispose (including pledge and otherwise encumber) of any unvested Restricted Shares, unless the Participant requests to do so in writing and the Committee consents to same in writing. The same applies to any transactions which, from an economic perspective, are similar to a disposition of unvested Restricted Shares.

SC1:4610533.3


(b)The Committee's consent to a disposal by a Participant to a legal entity controlled and solely represented by such Participant or to a member of his/her family shall not unreasonably be withheld.
7.Compliance with Securities Laws. The Company will not be required to deliver any certificates in respect of Restricted Shares pursuant to this Agreement, if, in the discretion of the Committee (or its delegate), such issuance would violate any applicable securities laws or stock exchange and other regulatory requirements. Prior to the vesting of or issuance of any certificates in respect of Restricted Shares pursuant to this Agreement, the Company may require that the Participant (or the Participant’s legal representative upon the Participants’ death or Disability, as applicable) enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable laws or with this Agreement.
8.Amendment. This Agreement may be amended by the Committee at any time, provided that, except as otherwise provided in the Director Plan, no such amendment, without the written consent of the Participant, shall materially adversely impair the rights of the Participant granted hereunder.
9.Miscellaneous.
(a)Headings. The headings in this Agreement are inserted for convenience only and shall have no significance in the interpretation of this Agreement.
(b)Entire Agreement. This Agreement, the Notice of Grant and the Director Plan contain the entire agreement between the parties with respect to the transactions contemplated hereunder and supersede any prior arrangements or understandings with respect thereto, written or oral. No agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not set forth expressly in this Agreement, including the Director Plan and any and all attachments hereto.
(c)Successors and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom the Restricted Shares may be transferred by will or the laws of descent and distribution.
(d)Repatriation. If the Participant is resident outside of the United States, the Participant agrees as a condition of the grant of the Restricted Shares to repatriate all payments attributable to the Restricted Shares acquired under the Director Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Restricted Shares once vested) if required by and in accordance with local foreign exchange rules and

SC1:4610533.3


regulations in the Participant’s country of residence. In addition, the Participant also agrees to take any and all actions, and consent to any and all actions taken by the Company and its subsidiaries, as may be required to allow the Company and its subsidiaries to comply with local laws, rules and regulations in the Participant’s country of residence. Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal legal and tax obligations under local laws, rules and regulations in the Participant’s country of residence.
(e)Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without reference to principles of conflict of laws.
(f)CONSENT TO JURISDICTION. BY ACCEPTING THIS AWARD, THE PARTICIPANT EXPRESSLY AND IRREVOCABLY AGREES TO SUBMIT TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL OR STATE COURT LOCATED IN NEW YORK, NEW YORK, U.S.A. IN RESPECT OF ANY MATTER HEREUNDER. This includes any action or proceeding to compel arbitration or to enforce an arbitration award.
10.Severability. The invalidity or unenforceability of any provision of the Director Plan or this Agreement shall not affect the validity or enforceability of any other provision of the Director Plan or this Agreement.
11.Electronic Delivery.  The Company may, in its sole discretion, deliver any documents related to the Restricted Shares by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Director Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
12.Employee Data Privacy.  The Participant hereby explicitly consents to the collection, use and transfer, in electronic or other form, of the Participant’s personal data as described in this document by and among, as applicable, the Company and its subsidiaries for the exclusive purpose of implementing, administering and managing the Participant’s participation in the Director Plan. The Participant understands that the Company holds certain personal information about the Participant, including, but not limited to, the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any Restricted Shares or any other entitlement, for the purpose of implementing, administering, and managing the Director Plan (“Data”). The Participant understands that Data may be transferred to any third parties assisting the Company in the implementation, administration, and management of the Director Plan, that these recipients may be located in the Participant’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Participant’s country. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local Human Resources representative. The Participant authorizes

SC1:4610533.3


the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Director Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any Restricted Shares or Shares acquired. The Participant understands that Data will be held only as long as is necessary to implement, administer, and manage the Participant’s participation in the Director Plan. The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant’s local Human Resources representative. The Participant understands, however, that refusing or withdrawing the Participant’s consent may affect the Participant’s ability to participate in the Director Plan (and may result in the forfeiture of unvested Restricted Shares). For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Company’s General Counsel or head of Human Resources.  
13.Acceptance. The Participant hereby acknowledges receipt of a copy of the Director Plan and this Agreement. The Participant has read and understands the terms and provisions thereof, and accepts the Restricted Shares subject to all of the terms and conditions of the Director Plan and this Agreement. The Participant acknowledges that there may be tax consequences upon the vesting or disposition of the Restricted Shares and that the Participant has been advised to consult a tax advisor prior to such vesting, settlement or disposition.
IN WITNESS WHEREOF, this Agreement has been executed by the Company and accepted by the Participant, effective as of the date first above written.

ORION ENGINEERED CARBONS S.A.     

         
Name: 
Title:




1 Note to Draft: Number of restricted shares equals one-hundred-thousand ($100,000) USD divided by the closing price of the Company’s common stock on the NYSE on _________

SC1:4610533.3

Exhibit 31.2 Certification by Lorin Crenshaw pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.

I, Lorin Crenshaw, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Orion Engineered Carbons S.A.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 7, 2020
/s/ Lorin Crenshaw
Chief Financial Officer


Exhibit 31.1 Certification by Corning F. Painter pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.

I, Corning Painter, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Orion Engineered Carbons S.A.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 7, 2020
/s/ Corning Painter
Chief Executive Officer


Exhibit 32.2 Certification by Lorin Crenshaw pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

CERTIFICATION
In connection with the Quarterly Report of Orion Engineered Carbons S.A. on Form 10-Q for the quarterly period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lorin Crenshaw, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 7, 2020
/s/ Lorin Crenshaw
Chief Financial Officer


Exhibit 32.1 Certification by Corning F. Painter pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
CERTIFICATION

In connection with the Quarterly Report of Orion Engineered Carbons S.A. on Form 10-Q for the quarterly period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Corning Painter, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 7, 2020
/s/ Corning Painter
Chief Executive Officer